Year |
Citation |
Score |
2024 |
Hardaker EL, Sanseviero E, Karmokar A, Taylor D, Milo M, Michaloglou C, Hughes A, Mai M, King M, Solanki A, Magiera L, Miragaia R, Kar G, Standifer N, Surace M, ... ... Gabrilovich DI, et al. The ATR inhibitor ceralasertib potentiates cancer checkpoint immunotherapy by regulating the tumor microenvironment. Nature Communications. 15: 1700. PMID 38402224 DOI: 10.1038/s41467-024-45996-4 |
0.47 |
|
2023 |
von Wulffen M, Luehrmann V, Robeck S, Russo A, Fischer-Riepe L, van den Bosch M, van Lent P, Loser K, Gabrilovich DI, Hermann S, Roth J, Vogl T. S100A8/A9-alarmin promotes local myeloid-derived suppressor cell activation restricting severe autoimmune arthritis. Cell Reports. 42: 113006. PMID 37610870 DOI: 10.1016/j.celrep.2023.113006 |
0.366 |
|
2023 |
Kim R, Taylor D, Vonderheide RH, Gabrilovich DI. Ferroptosis of immune cells in the tumor microenvironment. Trends in Pharmacological Sciences. PMID 37380530 DOI: 10.1016/j.tips.2023.06.005 |
0.481 |
|
2023 |
Bianchi A, De Castro Silva I, Deshpande NU, Singh S, Mehra S, Garrido VT, Guo X, Nivelo LA, Kolonias DS, Saigh SJ, Wieder E, Rafie CI, Dosch AR, Zhou Z, Umland O, ... ... Gabrilovich DI, et al. Cell-autonomous Cxcl1 sustains tolerogenic circuitries and stromal inflammation via neutrophil-derived TNF in pancreatic cancer. Cancer Discovery. PMID 36946782 DOI: 10.1158/2159-8290.CD-22-1046 |
0.473 |
|
2023 |
Lin C, Garcia-Gerique L, Bonner EE, Mastio J, Rosenwasser M, Cruz Z, Lawler M, Bernabei L, Muthumani K, Liu Q, Poncz M, Vogl T, Törngren M, Eriksson H, Vogl DT, ... Gabrilovich DI, et al. S100A8/S100A9 Promote Progression of Multiple Myeloma via Expansion of Megakaryocytes. Cancer Research Communications. 3: 420-430. PMID 36923707 DOI: 10.1158/2767-9764.CRC-22-0368 |
0.394 |
|
2023 |
van Vlerken-Ysla L, Tyurina YY, Kagan VE, Gabrilovich DI. Functional states of myeloid cells in cancer. Cancer Cell. PMID 36868224 DOI: 10.1016/j.ccell.2023.02.009 |
0.399 |
|
2023 |
Barry ST, Gabrilovich DI, Sansom OJ, Campbell AD, Morton JP. Therapeutic targeting of tumour myeloid cells. Nature Reviews. Cancer. PMID 36747021 DOI: 10.1038/s41568-022-00546-2 |
0.35 |
|
2022 |
Fu S, Deng H, Bertolini I, Perego M, Chen ES, Sanseviero E, Mostafa A, Alicea-Torres K, Garcia-Gerique L, Stone EL, Kossenkov AV, Schug ZT, Nam B, Mulligan C, Altieri DC, ... ... Gabrilovich DI, et al. Syntaphilin regulates neutrophil migration in cancer. Cancer Immunology Research. PMID 36548516 DOI: 10.1158/2326-6066.CIR-22-0035 |
0.441 |
|
2022 |
Kim R, Hashimoto A, Markosyan N, Tyurin VA, Tyurina YY, Kar G, Fu S, Sehgal M, Garcia-Gerique L, Kossenkov A, Gebregziabher BA, Tobias JW, Hicks K, Halpin RA, Cvetesic N, ... ... Gabrilovich DI, et al. Ferroptosis of tumour neutrophils causes immune suppression in cancer. Nature. PMID 36385526 DOI: 10.1038/s41586-022-05443-0 |
0.372 |
|
2022 |
Zhang H, Tomar VS, Li J, Basavaraja R, Yan F, Gui J, McBrearty N, Costich TL, Beiting DP, Blanco MA, Nefedova Y, Conejo-Garcia JR, Saggu G, Berger AJ, Gabrilovich DI, et al. Protection of regulatory T cells from fragility and inactivation in the tumor microenvironment. Cancer Immunology Research. PMID 36255418 DOI: 10.1158/2326-6066.CIR-22-0295 |
0.492 |
|
2022 |
Tcyganov EN, Sanseviero E, Marvel D, Beer T, Tang HY, Hembach P, Speicher DW, Zhang Q, Donthireddy LR, Mostafa A, Tsyganova S, Pisarev V, Laufer T, Ignatov D, Ferrone S, ... ... Gabrilovich DI, et al. Peroxynitrite in the tumor microenvironment changes the profile of antigens allowing escape from cancer immunotherapy. Cancer Cell. 40: 1173-1189.e6. PMID 36220073 DOI: 10.1016/j.ccell.2022.09.001 |
0.4 |
|
2022 |
Deng H, Lin C, Garcia-Gerique L, Fu S, Cruz Z, Bonner EE, Rosenwasser M, Rajagopal S, Sadhu MN, Gajendran C, Zainuddin M, Gosu R, Sivanandhan D, Shelef MA, Nam B, ... ... Gabrilovich DI, et al. A novel selective inhibitor JBI-589 targets PAD4-mediated neutrophil migration to suppress tumor progression. Cancer Research. PMID 36069973 DOI: 10.1158/0008-5472.CAN-21-4045 |
0.364 |
|
2022 |
Jiménez-Cortegana C, Galassi C, Klapp V, Gabrilovich DI, Galluzzi L. Myeloid-Derived Suppressor Cells and Radiotherapy. Cancer Immunology Research. 10: 545-557. PMID 35426936 DOI: 10.1158/2326-6066.CIR-21-1105 |
0.411 |
|
2022 |
Donthireddy L, Vonteddu P, Murthy T, Kwak T, Eraslan RN, Podojil JR, Elhofy A, Boyne MT, Puisis JJ, Veglia F, Singh SS, Dotiwala F, Montaner LJ, Gabrilovich DI. ONP-302 Nanoparticles Inhibit Tumor Growth By Altering Tumor-Associated Macrophages And Cancer-Associated Fibroblasts. Journal of Cancer. 13: 1933-1944. PMID 35399717 DOI: 10.7150/jca.69338 |
0.392 |
|
2021 |
Hicks KC, Tyurina YY, Kagan VE, Gabrilovich DI. Myeloid Cell-Derived Oxidized Lipids and Regulation of the Tumor Microenvironment. Cancer Research. PMID 34764204 DOI: 10.1158/0008-5472.CAN-21-3054 |
0.416 |
|
2021 |
Grover A, Sanseviero E, Timosenko E, Gabrilovich DI. Myeloid-Derived Suppressor Cells: A Propitious Road to Clinic. Cancer Discovery. 11: 2693-2706. PMID 34635571 DOI: 10.1158/2159-8290.CD-21-0764 |
0.369 |
|
2021 |
Hashimoto A, Sarker D, Reebye V, Jarvis S, Sodergren MH, Kossenkov A, Sanseviero E, Raulf N, Vasara J, Andrikakou P, Meyer T, Huang KW, Plummer R, Chee CE, Spalding D, ... ... Gabrilovich DI, et al. Up-regulation of C/EBPα inhibits suppressive activity of myeloid cells and potentiates antitumor response in mice and cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34407972 DOI: 10.1158/1078-0432.CCR-21-0986 |
0.334 |
|
2021 |
Gabrilovich DI. The Dawn of Myeloid-Derived Suppressor Cells: Identification of Arginase I as the Mechanism of Immune Suppression. Cancer Research. 81: 3953-3955. PMID 34341063 DOI: 10.1158/0008-5472.CAN-21-1237 |
0.485 |
|
2021 |
Tcyganov EN, Hanabuchi S, Hashimoto A, Campbell D, Kar G, Slidel TW, Cayatte C, Landry A, Pilataxi F, Hayes S, Dougherty B, Hicks KC, Mulgrew K, Tang CA, Hu CA, ... ... Gabrilovich DI, et al. Distinct mechanisms govern populations of myeloid-derived suppressor cells in chronic viral infection and cancer. The Journal of Clinical Investigation. PMID 34228641 DOI: 10.1172/JCI145971 |
0.4 |
|
2021 |
Alicea-Torres K, Sanseviero E, Gui J, Chen J, Veglia F, Yu Q, Donthireddy L, Kossenkov A, Lin C, Fu S, Mulligan C, Nam B, Masters G, Denstman F, Bennett J, ... ... Gabrilovich DI, et al. Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway. Nature Communications. 12: 1717. PMID 33741967 DOI: 10.1038/s41467-021-22033-2 |
0.46 |
|
2021 |
Veglia F, Hashimoto A, Dweep H, Sanseviero E, De Leo A, Tcyganov E, Kossenkov A, Mulligan C, Nam B, Masters G, Patel J, Bhargava V, Wilkinson P, Smirnov D, Sepulveda MA, ... ... Gabrilovich DI, et al. Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice. The Journal of Experimental Medicine. 218. PMID 33566112 DOI: 10.1084/jem.20201803 |
0.444 |
|
2021 |
Veglia F, Sanseviero E, Gabrilovich DI. Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity. Nature Reviews. Immunology. PMID 33526920 DOI: 10.1038/s41577-020-00490-y |
0.392 |
|
2021 |
Hao X, Zhao B, Zhou W, Liu H, Fukumoto T, Gabrilovich D, Zhang R. Sensitization of ovarian tumor to immune checkpoint blockade by boosting senescence-associated secretory phenotype. Iscience. 24: 102016. PMID 33490922 DOI: 10.1016/j.isci.2020.102016 |
0.447 |
|
2021 |
Somasundaram R, Connelly T, Choi R, Choi H, Samarkina A, Li L, Gregorio E, Chen Y, Thakur R, Abdel-Mohsen M, Beqiri M, Kiernan M, Perego M, Wang F, Xiao M, ... ... Gabrilovich D, et al. Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy. Nature Communications. 12: 346. PMID 33436641 DOI: 10.1038/s41467-020-20600-7 |
0.352 |
|
2021 |
Sanseviero E, Kim R, Gabrilovich DI. Isolation and Phenotyping of Splenic Myeloid-Derived Suppressor Cells in Murine Cancer Models. Methods in Molecular Biology (Clifton, N.J.). 2236: 19-28. PMID 33237537 DOI: 10.1007/978-1-0716-1060-2_3 |
0.398 |
|
2020 |
Kwak T, Wang F, Deng H, Condamine T, Kumar V, Perego M, Kossenkov A, Montaner LJ, Xu X, Xu W, Zheng C, Schuchter LM, Amaravadi RK, Mitchell TC, Karakousis GC, ... ... Gabrilovich DI, et al. Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in Cancer. Cell Reports. 33: 108571. PMID 33378668 DOI: 10.1016/j.celrep.2020.108571 |
0.356 |
|
2020 |
Perego M, Tyurin VA, Tyurina YY, Yellets J, Nacarelli T, Lin C, Nefedova Y, Kossenkov A, Liu Q, Sreedhar S, Pass H, Roth J, Vogl T, Feldser D, Zhang R, ... ... Gabrilovich DI, et al. Reactivation of dormant tumor cells by modified lipids derived from stress-activated neutrophils. Science Translational Medicine. 12. PMID 33268511 DOI: 10.1126/scitranslmed.abb5817 |
0.376 |
|
2020 |
Douglass SM, Fane ME, Sanseviero E, Ecker BL, Kugel CH, Behera R, Kumar V, Tcyganov EN, Yin X, Liu Q, Chhabra Y, Alicea GM, Kuruvilla R, Gabrilovich DI, Weeraratna AT. Myeloid-derived suppressor cells are a major source of Wnt5A in the melanoma microenvironment and depend on Wnt5A for full suppressive activity. Cancer Research. PMID 33262126 DOI: 10.1158/0008-5472.CAN-20-1238 |
0.409 |
|
2020 |
Barnoud T, Leung JC, Leu JI, Basu S, Poli ANR, Parris JLD, Indeglia A, Martynyuk T, Good M, Gnanapradeepan K, Sanseviero E, Moeller R, Tang HY, Cassel J, Kossenkov AV, ... ... Gabrilovich DI, et al. A novel inhibitor of HSP70 induces mitochondrial toxicity and immune cell recruitment in tumors. Cancer Research. PMID 33023943 DOI: 10.1158/0008-5472.CAN-20-0397 |
0.368 |
|
2020 |
Payne KK, Mine JA, Biswas S, Chaurio RA, Perales-Puchalt A, Anadon CM, Costich TL, Harro CM, Walrath J, Ming Q, Tcyganov E, Buras AL, Rigolizzo KE, Mandal G, Lajoie J, ... ... Gabrilovich DI, et al. BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells. Science (New York, N.Y.). 369: 942-949. PMID 32820120 DOI: 10.1126/Science.Aay2767 |
0.517 |
|
2020 |
Sharma G, Ojha R, Noguera-Ortega E, Rebecca VW, Attanasio J, Liu S, Piao S, Lee JJ, Nicastri MC, Harper SL, Ronghe A, Jain V, Winkler JD, Speicher DW, Mastio J, ... ... Gabrilovich DI, et al. PPT1 Inhibition enhances the anti-tumor activity of anti-PD-1 antibody in melanoma. Jci Insight. PMID 32780726 DOI: 10.1172/Jci.Insight.133225 |
0.489 |
|
2020 |
Gabrilovich DI. All Myeloid-Derived Suppressor Cells Are Not Created Equal: How Gender Inequality Influences These Cells and Affects Cancer Therapy. Cancer Discovery. 10: 1100-1102. PMID 32747371 DOI: 10.1158/2159-8290.Cd-20-0494 |
0.43 |
|
2020 |
Ugolini A, Tyurin V, Tyurina Y, Tsyganov E, Donthireddy L, Kagan VE, Gabrilovich DI, Veglia F. Polymorphonuclear myeloid-derived suppressor cells limit antigen cross-presentation by dendritic cells in cancer. Jci Insight. PMID 32584791 DOI: 10.1172/jci.insight.138581 |
0.413 |
|
2020 |
Alicea GM, Rebecca VW, Goldman AR, Fane ME, Douglass SM, Behera R, Webster MR, Kugel CH, Ecker BL, Caino MC, Kossenkov AV, Tang HY, Frederick DT, Flaherty KT, Xu X, ... ... Gabrilovich DI, et al. Changes in Aged Fibroblast Lipid Metabolism Induce Age-dependent Melanoma Cell Resistance to Targeted Therapy Via the Fatty Acid Transporter FATP2. Cancer Discovery. PMID 32499221 DOI: 10.1158/2159-8290.Cd-20-0329 |
0.316 |
|
2020 |
Hashimoto A, Fukumoto T, Zhang R, Gabrilovich D. Selective targeting of different populations of myeloid-derived suppressor cells by histone deacetylase inhibitors. Cancer Immunology, Immunotherapy : Cii. PMID 32435850 DOI: 10.1007/s00262-020-02588-7 |
0.384 |
|
2020 |
Kapralov AA, Yang Q, Dar HH, Tyurina YY, Anthonymuthu TS, Kim R, St Croix CM, Mikulska-Ruminska K, Liu B, Shrivastava IH, Tyurin VA, Ting HC, Wu YL, Gao Y, Shurin GV, ... ... Gabrilovich DI, et al. Redox lipid reprogramming commands susceptibility of macrophages and microglia to ferroptotic death. Nature Chemical Biology. 16: 278-290. PMID 32080625 DOI: 10.1038/S41589-019-0462-8 |
0.329 |
|
2020 |
Atay C, Kwak T, Lavilla-Alonso S, Richards A, Moberg V, Pilon-Thomas S, Schell M, Messina JL, Rebecca VW, Zhang G, Weber JS, Herlyn M, Sarnaik AA, Gabrilovich DI. Abstract B41: BRAF targeting sensitizes resistant melanoma to cytotoxic T cells Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm18-B41 |
0.474 |
|
2020 |
Fuchs S, Alicea-Torres KM, Gabrilovich DI. Abstract A72: IFNAR1 signaling regulates PMN-MDSCs immune suppressive activity in cancer Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm18-A72 |
0.535 |
|
2020 |
Tcyganov EN, Gabrilovich DI. Abstract 6615: Peroxynitrite mediates immune escape of tumor cells from cytotoxic T cells in situ Immunology. 80: 6615-6615. DOI: 10.1158/1538-7445.Am2020-6615 |
0.52 |
|
2020 |
Douglass S, Fane M, Sanseviero E, Gabrilovich D, Weeraratna A. Abstract 2656: Myeloid derived Wnt5a influences the immune-dynamics of melanoma tumor microenvironment Tumor Biology. DOI: 10.1158/1538-7445.Am2020-2656 |
0.431 |
|
2019 |
Kagan VE, Tyurina YY, Sun WY, Vlasova LL, Dar H, Tyurin VA, Amoscato AA, Mallampalli R, van der Wel PCA, He RR, Shvedova AA, Gabrilovich D, Bayir H. Redox phospholipidomics of enzymatically generated oxygenated phospholipids as specific signals of programmed cell death. Free Radical Biology & Medicine. PMID 31883467 DOI: 10.1016/J.Freeradbiomed.2019.12.028 |
0.319 |
|
2019 |
Seo JH, Chae YC, Kossenkov AV, Lee YG, Tang HY, Agarwal E, Gabrilovich DI, Languino LR, Speicher DW, Shastrula PK, Storaci AM, Ferrero S, Gaudioso G, Caroli M, Tosi D, et al. MFF REGULATION OF MITOCHONDRIAL CELL DEATH IS A THERAPEUTIC TARGET IN CANCER. Cancer Research. PMID 31582380 DOI: 10.1158/0008-5472.Can-19-1982 |
0.394 |
|
2019 |
Liu Y, Perego M, Xiao Q, He Y, Fu S, He J, Liu W, Li X, Tang Y, Li X, Yuan W, Zhou W, Wu F, Jia C, Cui Q, ... ... Gabrilovich DI, et al. Lactoferrin-induced myeloid-derived suppressor cell therapy attenuates pathologic inflammatory conditions in newborn mice. The Journal of Clinical Investigation. PMID 31483289 DOI: 10.1172/Jci128164 |
0.417 |
|
2019 |
Fukumoto T, Fatkhutdinov N, Zundell JA, Tcyganov EN, Nacarelli T, Karakashev S, Wu S, Liu Q, Gabrilovich DI, Zhang R. HDAC6 inhibition synergizes with anti-PD-L1 therapy in ARID1A-inactivated ovarian cancer. Cancer Research. PMID 31311810 DOI: 10.1158/0008-5472.Can-19-1302 |
0.475 |
|
2019 |
Mastio J, Condamine T, Dominguez G, Kossenkov AV, Donthireddy L, Veglia F, Lin C, Wang F, Fu S, Zhou J, Viatour P, Lavilla-Alonso S, Polo AT, Tcyganov EN, Mulligan C, ... ... Gabrilovich DI, et al. Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs. The Journal of Experimental Medicine. PMID 31239386 DOI: 10.1084/Jem.20181952 |
0.547 |
|
2019 |
Agarwal E, Altman BJ, Seo JH, Ghosh JC, Kossenkov AV, Tang HY, Krishn SR, Languino LR, Gabrilovich DI, Speicher DW, Dang CV, Altieri DC. Myc-mediated transcriptional regulation of the mitochondrial chaperone TRAP1 controls primary and metastatic tumor growth. The Journal of Biological Chemistry. PMID 31097545 DOI: 10.1074/Jbc.Ac119.008656 |
0.461 |
|
2019 |
Agarwal E, Altman BJ, Seo JH, Bertolini I, Ghosh JC, Kaur A, Kossenkov AV, Languino LR, Gabrilovich DI, Speicher DW, Dang CV, Altieri DC. MYC REGULATION OF A MITOCHONDRIAL TRAFFICKING NETWORK MEDIATES TUMOR CELL INVASION AND METASTASIS. Molecular and Cellular Biology. PMID 31061095 DOI: 10.1128/Mcb.00109-19 |
0.401 |
|
2019 |
Veglia F, Tyurin VA, Blasi M, De Leo A, Kossenkov AV, Donthireddy L, To TKJ, Schug Z, Basu S, Wang F, Ricciotti E, DiRusso C, Murphy ME, Vonderheide RH, Lieberman PM, ... ... Gabrilovich DI, et al. Fatty acid transport protein 2 reprograms neutrophils in cancer. Nature. PMID 30996346 DOI: 10.1038/S41586-019-1118-2 |
0.446 |
|
2019 |
Cao Y, Yang Q, Deng H, Tang J, Hu J, Liu H, Zhi M, Ye L, Zou B, Liu Y, Wei L, Gabrilovich DI, Wang H, Zhou J. Transcriptional factor ATF3 protects against colitis by regulating follicular helper T cells in Peyer's patches. Proceedings of the National Academy of Sciences of the United States of America. PMID 30862736 DOI: 10.1073/Pnas.1818164116 |
0.32 |
|
2019 |
Atay C, Kwak T, Lavilla-Alonso S, Donthireddy L, Richards AD, Moberg VE, Pilon-Thomas S, Schell MJ, Messina JL, Rebecca VW, Xiao M, Tan J, Zhang G, Weber JS, Herlyn M, ... ... Gabrilovich DI, et al. BRAF targeting sensitizes resistant melanoma to cytotoxic T cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30765391 DOI: 10.1158/1078-0432.Ccr-18-2725 |
0.394 |
|
2019 |
Gabrilovich DI. Abstract IA10: PMN-MDSC and neutrophils: Tale of two cells in cancer Cancer Immunology Research. 7. DOI: 10.1158/2326-6074.Cricimteatiaacr18-Ia10 |
0.54 |
|
2019 |
Lin C, Herlihy SE, Li M, Deng H, Bernabei L, Gabrilovich DI, Vogl DT, Nefedova Y. Abstract 2103: NETs promote tumor resistance to anthracyclines Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2103 |
0.357 |
|
2018 |
Chiappori AA, Williams CC, Gray JE, Tanvetyanon T, Haura EB, Creelan BC, Thapa R, Chen DT, Simon GR, Bepler G, Gabrilovich DI, Antonia SJ. Randomized-controlled phase II trial of salvage chemotherapy after immunization with a TP53-transfected dendritic cell-based vaccine (Ad.p53-DC) in patients with recurrent small cell lung cancer. Cancer Immunology, Immunotherapy : Cii. PMID 30591959 DOI: 10.1007/S00262-018-2287-9 |
0.376 |
|
2018 |
Kim HR, Park SM, Seo SU, Jung I, Yoon HI, Gabrilovich DI, Cho BC, Seong SY, Ha SJ, Youn JI. The Ratio of Peripheral Regulatory T Cells to Lox-1 PMN-MDSC Predicts the Early Response to Anti-PD-1 Therapy in Non-Small Cell Lung Cancer Patients. American Journal of Respiratory and Critical Care Medicine. PMID 30339766 DOI: 10.1164/Rccm.201808-1502Le |
0.628 |
|
2018 |
Patel S, Fu S, Mastio J, Dominguez GA, Purohit A, Kossenkov A, Lin C, Alicea-Torres K, Sehgal M, Nefedova Y, Zhou J, Languino LR, Clendenin C, Vonderheide RH, Mulligan C, ... ... Gabrilovich DI, et al. Unique pattern of neutrophil migration and function during tumor progression. Nature Immunology. PMID 30323345 DOI: 10.1038/S41590-018-0229-5 |
0.496 |
|
2018 |
Kumar S, Wilkes DW, Samuel N, Blanco MA, Nayak A, Alicea-Torres K, Gluck C, Sinha S, Gabrilovich D, Chakrabarti R. ΔNp63-driven recruitment of myeloid-derived suppressor cells promotes metastasis in triple-negative breast cancer. The Journal of Clinical Investigation. PMID 30295647 DOI: 10.1172/Jci99673 |
0.51 |
|
2018 |
Hashimoto A, Gao C, Mastio J, Kossenkov A, Abrams SI, Purandare AV, Desilva H, Wee S, Hunt JT, Jure-Kunkel M, Gabrilovich DI. Inhibition of casein kinase 2 disrupts differentiation of myeloid cells in cancer and enhances the efficacy of immunotherapy in mice. Cancer Research. PMID 30139814 DOI: 10.1158/0008-5472.Can-18-1229 |
0.558 |
|
2018 |
Seo JH, Agarwal E, Bryant KG, Caino MC, Kim ET, Kossenkov AV, Tang HY, Languino LR, Gabrilovich DI, Cohen AR, Speicher DW, Altieri DC. Syntaphilin Ubiquitination Regulates Mitochondrial Dynamics And Tumor Cell Movements. Cancer Research. PMID 29898993 DOI: 10.1158/0008-5472.Can-18-0595 |
0.408 |
|
2018 |
Kugel CH, Douglass SM, Webster MR, Kaur A, Liu Q, Yin X, Weiss SA, Darvishian F, Al-Rohil RN, Ndoye A, Behera R, Alicea GM, Ecker BL, Fane M, Allegrezza MJ, ... ... Gabrilovich D, et al. Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29898988 DOI: 10.1158/1078-0432.Ccr-18-1116 |
0.36 |
|
2018 |
Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, Coussens LM, Gabrilovich DI, Ostrand-Rosenberg S, Hedrick CC, Vonderheide RH, Pittet MJ, Jain RK, Zou W, Howcroft TK, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nature Medicine. PMID 29686425 DOI: 10.1038/S41591-018-0014-X |
0.441 |
|
2018 |
Tang CA, Chang S, Hashimoto A, Chen YJ, Kang CW, Mato AR, Del Valle JR, Gabrilovich D, Hu CA. Secretory IgM exacerbates tumor progression by inducing accumulations of MDSCs in mice. Cancer Immunology Research. PMID 29650518 DOI: 10.1158/2326-6066.Cir-17-0582 |
0.47 |
|
2018 |
Tcyganov E, Mastio J, Chen E, Gabrilovich DI. Plasticity of myeloid-derived suppressor cells in cancer. Current Opinion in Immunology. 51: 76-82. PMID 29547768 DOI: 10.1016/J.Coi.2018.03.009 |
0.532 |
|
2018 |
Veglia F, Perego M, Gabrilovich D. Myeloid-derived suppressor cells coming of age. Nature Immunology. PMID 29348500 DOI: 10.1038/S41590-017-0022-X |
0.453 |
|
2018 |
He YM, Li X, Perego M, Nefedova Y, Kossenkov AV, Jensen EA, Kagan V, Liu YF, Fu SY, Ye QJ, Zhou YH, Wei L, Gabrilovich DI, Zhou J. Transitory presence of myeloid-derived suppressor cells in neonates is critical for control of inflammation. Nature Medicine. PMID 29334374 DOI: 10.1038/nm.4467 |
0.341 |
|
2018 |
Dominguez G, Sholevar C, Polo A, Roop J, Campisi A, Gabrilovich D, Rauscher FJ, Kumar A. The coupling of MDSCs with a computational analytic method to detect solid tumors. Journal of Clinical Oncology. 36: 24-24. DOI: 10.1200/Jco.2018.36.5_Suppl.24 |
0.421 |
|
2018 |
Gandhi L, Janne PA, Opyrchal M, Ramalingam SS, Rybkin II, Hafez N, Raez LE, Gabrilovich D, Wang F, Ordentlich P, Brouwer S, Sankoh S, Schmidt EV, Meyers ML, Hellmann MD. Efficacy and safety of entinostat (ENT) and pembrolizumab (PEMBRO) in patients with non-small cell lung cancer (NSCLC) previously treated with anti-PD-(L)1 therapy. Journal of Clinical Oncology. 36: 9036-9036. DOI: 10.1200/Jco.2018.36.15_Suppl.9036 |
0.327 |
|
2018 |
Gabrilovich D. Abstract BS1-2: Myeloid-derived suppressor cells: many facets of regulation of tumor progression Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-Bs1-2 |
0.57 |
|
2018 |
Tolcher AW, Meyers ML, Gabrilovich D, Wang F, Trepel J, Lee M, Schmitt E, Quaranto C, Sankoh S, Tamang D, Ordentlich P. Abstract CT179: Safety, efficacy, and immune correlates of alternative doses and schedules of entinostat combined with pembrolizumab in patients with advanced solid tumors - results from SNDX-275-0141 phase I trial Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Ct179 |
0.409 |
|
2018 |
Veglia F, Tyurin VA, Kagan VE, Gabrilovich D. Abstract 5133: Lipids and suppressive functions of MDSC in cancer Cancer Research. 78: 5133-5133. DOI: 10.1158/1538-7445.Am2018-5133 |
0.433 |
|
2018 |
Tang C, Chang S, Hashimoto A, Chen Y, Kang CW, Mato A, Valle JD, Gabrilovich D, Hu CA. Abstract 4756: Secretory IgM exacerbates tumor progression by inducing accumulations of myeloid-derived suppressor cells in mice Cancer Research. 78: 4756-4756. DOI: 10.1158/1538-7445.Am2018-4756 |
0.477 |
|
2018 |
Dominguez GA, Maslar K, Polo A, Sholevar C, Campisi A, Roop J, Gabrilovich D, Rauscher F, Kumar A. Abstract 1582: The coupling of MDSCs with a computational neural network (NN) to detect solid tumors Cancer Research. 78: 1582-1582. DOI: 10.1158/1538-7445.Am2018-1582 |
0.423 |
|
2018 |
Atay C, Lavilla-Alonso S, Gabrilovich D. Abstract 1543: Upregulation of mannose 6-phosphate receptor (MPR) has a potential to increase the efficacy of combined therapy for melanoma patients Cancer Research. 78: 1543-1543. DOI: 10.1158/1538-7445.Am2018-1543 |
0.505 |
|
2018 |
Tcyganov EN, Gabrilovich DI. Abstract 1008: Peroxynitrite mediates the resistance of tumor cells to cytotoxic T cells by altering the MHC1-peptide repertoire on tumor cells Tumor Biology. DOI: 10.1158/1538-7445.Am2018-1008 |
0.493 |
|
2017 |
Zhou J, Nefedova Y, Lei A, Gabrilovich D. Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells. Seminars in Immunology. PMID 29254756 DOI: 10.1016/j.smim.2017.12.004 |
0.346 |
|
2017 |
Veglia F, Tyurin VA, Mohammadyani D, Blasi M, Duperret EK, Donthireddy L, Hashimoto A, Kapralov A, Amoscato A, Angelini R, Patel S, Alicea-Torres K, Weiner D, Murphy ME, Klein-Seetharaman J, ... ... Gabrilovich DI, et al. Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer. Nature Communications. 8: 2122. PMID 29242535 DOI: 10.1038/S41467-017-02186-9 |
0.487 |
|
2017 |
Kumar V, Donthireddy L, Marvel D, Condamine T, Wang F, Lavilla-Alonso S, Hashimoto A, Vonteddu P, Behera R, Goins MA, Mulligan C, Nam B, Hockstein N, Denstman F, Shakamuri S, ... ... Gabrilovich DI, et al. Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors. Cancer Cell. 32: 654-668.e5. PMID 29136508 DOI: 10.1016/J.Ccell.2017.10.005 |
0.464 |
|
2017 |
Caino MC, Seo JH, Wang Y, Rivadeneira DB, Gabrilovich DI, Kim ET, Weeraratna AT, Languino LR, Altieri DC. Syntaphilin controls a mitochondrial rheostat for proliferation-motility decisions in cancer. The Journal of Clinical Investigation. PMID 28891816 DOI: 10.1172/JCI93172 |
0.369 |
|
2017 |
Orillion A, Hashimoto A, Damayanti NP, Shen L, Adelaiye-Ogala R, Arisa S, Chintala S, Ordentlich P, Kao C, Elzey B, Gabrilovich D, Pili R. Entinostat neutralizes myeloid derived suppressor cells and enhances the antitumor effect of PD-1 inhibition in murine models of lung and renal cell carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28698201 DOI: 10.1158/1078-0432.Ccr-17-0741 |
0.486 |
|
2017 |
Gabrilovich D, Ferris RL. Editorial overview: Many shades of grey: how immune response is regulated by tumors. Current Opinion in Immunology. 45: ix-xi. PMID 28554483 DOI: 10.1016/J.Coi.2017.05.003 |
0.445 |
|
2017 |
Veglia F, Gabrilovich DI. Dendritic cells in cancer: the role revisited. Current Opinion in Immunology. 45: 43-51. PMID 28192720 DOI: 10.1016/j.coi.2017.01.002 |
0.42 |
|
2017 |
Gabrilovich DI. Myeloid-Derived Suppressor Cells. Cancer Immunology Research. 5: 3-8. PMID 28052991 DOI: 10.1158/2326-6066.Cir-16-0297 |
0.579 |
|
2017 |
Johnson ML, Gonzalez R, Opyrchal M, Gabrilovich D, Ordentlich P, Brouwer S, Sankoh S, Schmidt EV, Meyers ML, Agarwala SS. ENCORE 601: A phase II study of entinostat (ENT) in combination with pembrolizumab (PEMBRO) in patients with melanoma. Journal of Clinical Oncology. 35: 9529-9529. DOI: 10.1200/Jco.2017.35.15_Suppl.9529 |
0.317 |
|
2017 |
Tang C, Chang S, Paton A, Paton J, Gabrilovich D, Ploegh H, Valle JD, Hu CA. Abstract LB-336: Specific serine phosphorylation of IRE-1 controls enhanced splicing of XBP-1 and regulated IRE-1-dependent decay (RIDD) Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-336 |
0.372 |
|
2017 |
Dominguez GA, Condamine T, Mony S, Hashimoto A, Wang F, Liu Q, Forero A, Bendell JC, Witt R, Hockstein N, Kumar P, Gabrilovich DI. Abstract CT095: The selective targeting of myeloid-derived suppressor cells in cancer patients using an agonistic TRAIL-R2 antibody Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Ct095 |
0.42 |
|
2017 |
Hashimoto A, Kumar V, Ordentlich P, Gabrilovich DI. Abstract 5595: HDAC inhibitor Entinostat disrupts function of PMN-MDSC Cancer Research. 77: 5595-5595. DOI: 10.1158/1538-7445.Am2017-5595 |
0.551 |
|
2017 |
Herlihy S, Lin C, Ozeriva M, Garfall A, Vogl D, Gabrilovich D, Nefedova Y. Abstract 3980: Ly6G+ neutrophils and polymorphonuclear myeloid derived suppressor cells promote the survival of tumor cells Cancer Research. 77: 3980-3980. DOI: 10.1158/1538-7445.Am2017-3980 |
0.58 |
|
2017 |
Rivera CA, Dominguez GA, Tomov V, Falk GW, Ginsberg GG, Gabrilovich D, Rustgi AK, Lynch JP. Identification of Myeloid Derived Suppressor Cells in the Barrett’s Metaplasia to Esophageal Adenocarcinoma Sequence Gastroenterology. 152: S234. DOI: 10.1016/S0016-5085(17)31071-5 |
0.367 |
|
2016 |
Condamine T, Dominguez GA, Youn JI, Kossenkov AV, Mony S, Alicea-Torres K, Tcyganov E, Hashimoto A, Nefedova Y, Lin C, Partlova S, Garfall A, Vogl DT, Xu X, Knight SC, ... ... Gabrilovich DI, et al. Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients. Science Immunology. 1. PMID 28417112 DOI: 10.1126/Sciimmunol.Aaf8943 |
0.673 |
|
2016 |
Dominguez G, Condamine TC, Mony S, Hashimoto A, Wang F, Liu Q, Forero A, Bendell JC, Witt R, Hockstein N, Kumar P, Gabrilovich D. Selective targeting of myeloid-derived suppressor cells in cancer patients using DS-8273a, an agonistic TRAIL-R2 antibody. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27965309 DOI: 10.1158/1078-0432.Ccr-16-1784 |
0.377 |
|
2016 |
Sayeed A, Lu H, Liu Q, Deming Ii D, Duffy A, McCue P, Dicker AP, Davis RJ, Gabrilovich D, Rodeck U, Altieri DC, Languino LR. β1 integrin- and JNK-dependent tumor growth upon hypofractionated radiation. Oncotarget. PMID 27438371 DOI: 10.18632/Oncotarget.10522 |
0.379 |
|
2016 |
Bronte V, Brandau S, Chen SH, Colombo MP, Frey AB, Greten TF, Mandruzzato S, Murray PJ, Ochoa A, Ostrand-Rosenberg S, Rodriguez PC, Sica A, Umansky V, Vonderheide RH, Gabrilovich DI. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nature Communications. 7: 12150. PMID 27381735 DOI: 10.1038/Ncomms12150 |
0.471 |
|
2016 |
Kumar V, Cheng P, Condamine T, Mony S, Languino LR, McCaffrey JC, Hockstein N, Guarino M, Masters G, Penman E, Denstman F, Xu X, Altieri DC, Du H, Yan C, ... Gabrilovich DI, et al. CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation. Immunity. 44: 303-15. PMID 26885857 DOI: 10.1016/J.Immuni.2016.01.014 |
0.507 |
|
2016 |
Kumar V, Patel S, Tcyganov E, Gabrilovich DI. The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment. Trends in Immunology. PMID 26858199 DOI: 10.1016/J.It.2016.01.004 |
0.499 |
|
2016 |
Johnson ML, Adjei AA, Ramalingam SS, Janne PA, Dominguez G, Gabrilovich D, Deleon L, Hasapidis JL, Diede SJ, Ordentlich P, Hellmann MD. Preliminary results of ENCORE 601, a phase 1b/2, open-label study of entinostat (ENT) in combination with pembrolizumab (PEMBRO) in patients with non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 34: e20659-e20659. DOI: 10.1200/Jco.2016.34.15_Suppl.E20659 |
0.383 |
|
2015 |
Ramachandran IR, Condamine T, Lin C, Herlihy SE, Garfall A, Vogl DT, Gabrilovich DI, Nefedova Y. Bone marrow PMN-MDSCs and neutrophils are functionally similar in protection of multiple myeloma from chemotherapy. Cancer Letters. PMID 26639197 DOI: 10.1016/J.Canlet.2015.10.040 |
0.475 |
|
2015 |
Condamine T, Mastio J, Gabrilovich DI. Transcriptional regulation of myeloid-derived suppressor cells. Journal of Leukocyte Biology. 98: 913-22. PMID 26337512 DOI: 10.1189/Jlb.4Ri0515-204R |
0.547 |
|
2015 |
Gabrilovich D, Nefedova Y. ROR1C Regulates Differentiation of Myeloid-Derived Suppressor Cells. Cancer Cell. 28: 147-9. PMID 26267530 DOI: 10.1016/J.Ccell.2015.07.007 |
0.528 |
|
2015 |
Koehn BH, Apostolova P, Haverkamp JM, Miller JS, McCullar V, Tolar J, Munn DH, Murphy WJ, Brickey WJ, Serody JS, Gabrilovich DI, Bronte V, Murray PJ, Ting JP, Zeiser R, et al. GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells. Blood. 126: 1621-8. PMID 26265697 DOI: 10.1182/Blood-2015-03-634691 |
0.378 |
|
2015 |
Marvel D, Gabrilovich DI. Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected. The Journal of Clinical Investigation. 125: 3356-64. PMID 26168215 DOI: 10.1172/Jci80005 |
0.546 |
|
2015 |
Apetoh L, Smyth MJ, Drake CG, Abastado JP, Apte RN, Ayyoub M, Blay JY, Bonneville M, Butterfield LH, Caignard A, Castelli C, Cavallo F, Celis E, Chen L, Colombo MP, ... ... Gabrilovich DI, et al. Consensus nomenclature for CD8(+) T cell phenotypes in cancer. Oncoimmunology. 4: e998538. PMID 26137416 DOI: 10.1080/2162402X.2014.998538 |
0.457 |
|
2015 |
Gabrilovich D. Fatal attraction: How macrophages participate in tumor metastases Journal of Experimental Medicine. 212: 976-976. PMID 26122939 DOI: 10.1084/Jem.2127Insight1 |
0.435 |
|
2015 |
Locke FL, Menges M, Veerapathran A, Coppola D, Gabrilovich D, Anasetti C. Survivin-specific CD4+ T cells are decreased in patients with survivin-positive myeloma. Journal For Immunotherapy of Cancer. 3: 20. PMID 25992291 DOI: 10.1186/S40425-015-0065-1 |
0.405 |
|
2015 |
Ortiz ML, Kumar V, Martner A, Mony S, Donthireddy L, Condamine T, Seykora J, Knight SC, Malietzis G, Lee GH, Moorghen M, Lenox B, Luetteke N, Celis E, Gabrilovich D. Immature myeloid cells directly contribute to skin tumor development by recruiting IL-17-producing CD4+ T cells. The Journal of Experimental Medicine. 212: 351-67. PMID 25667306 DOI: 10.1084/Jem.20140835 |
0.528 |
|
2015 |
Condamine T, Ramachandran I, Youn JI, Gabrilovich DI. Regulation of tumor metastasis by myeloid-derived suppressor cells. Annual Review of Medicine. 66: 97-110. PMID 25341012 DOI: 10.1146/Annurev-Med-051013-052304 |
0.724 |
|
2015 |
Sahakian E, Powers JJ, Chen J, Deng SL, Cheng F, Distler A, Woods DM, Rock-Klotz J, Sodre AL, Youn JI, Woan KV, Villagra A, Gabrilovich D, Sotomayor EM, Pinilla-Ibarz J. Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function. Molecular Immunology. 63: 579-85. PMID 25155994 DOI: 10.1016/J.Molimm.2014.08.002 |
0.706 |
|
2015 |
Ramachandran I, Lin C, Condamine T, Ozerova M, Garfall A, Vogl D, Gabrilovich D, Nefedova Y. Abstract 5020: Neutrophils in the bone marrow niche promote multiple myeloma chemoresistance Cancer Research. 75: 5020-5020. DOI: 10.1158/1538-7445.Am2015-5020 |
0.51 |
|
2015 |
Veglia F, Tyurin V, Kagan V, Gabrilovich D. Abstract 467: Oxidized lipids contribute to the suppression function of myeloid derived suppressor cells in cancer Cancer Research. 75: 467-467. DOI: 10.1158/1538-7445.Am2015-467 |
0.465 |
|
2015 |
Marvel DM, Gabrilovich D. Abstract 4051: Protection from CTL mediated killing by iNOS expression in a mouse model of melanoma Cancer Research. 75: 4051-4051. DOI: 10.1158/1538-7445.Am2015-4051 |
0.509 |
|
2015 |
Condamine TC, Kumar V, Gabrilovich DI. Abstract 3176: Linking suppressive activity and ER-Stress in Myeloid Derived Suppressor Cells Cancer Research. 75: 3176-3176. DOI: 10.1158/1538-7445.Am2015-3176 |
0.479 |
|
2015 |
Mastio J, Condamine T, Gabrilovich D. Abstract 3174: Retinoblastoma protein 1 implication in the monocytic - granulocytic transition Cancer Research. 75: 3174-3174. DOI: 10.1158/1538-7445.Am2015-3174 |
0.52 |
|
2015 |
Kumar V, Cheng P, Condamine T, Gabrilovich D. Abstract 2343: Tumor microenvironment regulates the fate of myeloid cells by controlling STAT3 activity Cancer Research. 75: 2343-2343. DOI: 10.1158/1538-7445.Am2015-2343 |
0.561 |
|
2015 |
Lavilla-Alonso S, Brekken R, Gabrilovich D. Abstract 1337: Up-regulation of mannose 6-phosphate receptor induced by BRAF inhibitor PLX4720 is linked to phosphatidylserine externalization and shows positive effects for combination therapies Cancer Research. 75: 1337-1337. DOI: 10.1158/1538-7445.Am2015-1337 |
0.461 |
|
2014 |
Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, ... ... Gabrilovich DI, et al. Classification of current anticancer immunotherapies. Oncotarget. 5: 12472-508. PMID 25537519 DOI: 10.18632/Oncotarget.2998 |
0.433 |
|
2014 |
Gabrilovich DI. Editorial: The intricacy of choice: can bacteria decide what type of myeloid cells to stimulate? Journal of Leukocyte Biology. 96: 671-4. PMID 25360040 DOI: 10.1189/Jlb.4Ce0514-271R |
0.391 |
|
2014 |
Condamine T, Gabrilovich DI. Can the suppressive activity of myeloid-derived suppressor cells be "chop"ped? Immunity. 41: 341-2. PMID 25238087 DOI: 10.1016/J.Immuni.2014.08.016 |
0.485 |
|
2014 |
Kumar V, Gabrilovich DI. Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment. Immunology. 143: 512-9. PMID 25196648 DOI: 10.1111/Imm.12380 |
0.476 |
|
2014 |
Yang Q, Shi M, Shen Y, Cao Y, Zuo S, Zuo C, Zhang H, Gabrilovich DI, Yu Y, Zhou J. COX-1-derived thromboxane A2 plays an essential role in early B-cell development via regulation of JAK/STAT5 signaling in mouse. Blood. 124: 1610-21. PMID 25030064 DOI: 10.1182/Blood-2014-03-559658 |
0.384 |
|
2014 |
Kim S, Ramakrishnan R, Lavilla-Alonso S, Chinnaiyan P, Rao N, Fowler E, Heine J, Gabrilovich DI. Radiation-induced autophagy potentiates immunotherapy of cancer via up-regulation of mannose 6-phosphate receptor on tumor cells in mice. Cancer Immunology, Immunotherapy : Cii. 63: 1009-21. PMID 24943275 DOI: 10.1007/S00262-014-1573-4 |
0.52 |
|
2014 |
Condamine T, Kumar V, Ramachandran IR, Youn JI, Celis E, Finnberg N, El-Deiry WS, Winograd R, Vonderheide RH, English NR, Knight SC, Yagita H, McCaffrey JC, Antonia S, Hockstein N, ... ... Gabrilovich DI, et al. ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis. The Journal of Clinical Investigation. 124: 2626-39. PMID 24789911 DOI: 10.1172/Jci74056 |
0.699 |
|
2014 |
Ortiz ML, Lu L, Ramachandran I, Gabrilovich DI. Myeloid-derived suppressor cells in the development of lung cancer. Cancer Immunology Research. 2: 50-8. PMID 24778162 DOI: 10.1158/2326-6066.Cir-13-0129 |
0.448 |
|
2014 |
Senesac J, Gabrilovich D, Pirruccello S, Talmadge JE. Dendritic cells transfected with adenoviral vectors as vaccines Methods in Molecular Biology. 1139: 97-118. PMID 24619674 DOI: 10.1007/978-1-4939-0345-0_10 |
0.41 |
|
2014 |
Ramakrishnan R, Tyurin VA, Tuyrin VA, Veglia F, Condamine T, Amoscato A, Mohammadyani D, Johnson JJ, Zhang LM, Klein-Seetharaman J, Celis E, Kagan VE, Gabrilovich DI. Oxidized lipids block antigen cross-presentation by dendritic cells in cancer. Journal of Immunology (Baltimore, Md. : 1950). 192: 2920-31. PMID 24554775 DOI: 10.4049/Jimmunol.1302801 |
0.426 |
|
2014 |
Farren MR, Carlson LM, Netherby CS, Lindner I, Li PK, Gabrilovich DI, Abrams SI, Lee KP. Tumor-induced STAT3 signaling in myeloid cells impairs dendritic cell generation by decreasing PKCβII abundance. Science Signaling. 7: ra16. PMID 24550541 DOI: 10.1126/Scisignal.2004656 |
0.566 |
|
2014 |
Cheng P, Kumar V, Liu H, Youn JI, Fishman M, Sherman S, Gabrilovich D. Effects of notch signaling on regulation of myeloid cell differentiation in cancer. Cancer Research. 74: 141-52. PMID 24220241 DOI: 10.1158/0008-5472.Can-13-1686 |
0.695 |
|
2014 |
Liu H, Ramachandran I, Gabrilovich DI. Regulation of plasmacytoid dendritic cell development in mice by aryl hydrocarbon receptor. Immunology and Cell Biology. 92: 200-3. PMID 24165981 DOI: 10.1038/Icb.2013.65 |
0.443 |
|
2014 |
Cao W, Ramakrishnan R, Tuyrin VA, Veglia F, Condamine T, Amoscato A, Mohammadyani D, Johnson JJ, Zhang LM, Klein-Seetharaman J, Celis E, Kagan VE, Gabrilovich DI. Correction: Oxidized Lipids Block Antigen Cross-Presentation by Dendritic Cells in Cancer The Journal of Immunology. 192: 4935-4935. DOI: 10.4049/Jimmunol.1490017 |
0.339 |
|
2014 |
Raj SK, Indelicato DJ, Chiappori A, Conley AP, Gonzales R, Heysec R, Letson DD, Gabrilovich D, Bui MM, Finklestein S, Antonia SJ. Neoadjuvant administration of radiation therapy and intratumoral autologous dendritic cells in patients with localized high-risk soft tissue sarcomas. Journal of Clinical Oncology. 32: 10519-10519. DOI: 10.1200/Jco.2014.32.15_Suppl.10519 |
0.489 |
|
2014 |
Yopp A, Kallinteris N, Huang X, Shan J, Menander K, Freimark B, Hutchins J, King S, Gabrilovich DI, Brekken R. Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment Journal For Immunotherapy of Cancer. 2: P266. DOI: 10.1186/2051-1426-2-S3-P266 |
0.534 |
|
2014 |
Youn J, Lee K, Lee H, Gabrilovich DI. Loss of Rb1 by epigenetic modification regulates expansion of MDSC in cancer Journal For Immunotherapy of Cancer. 2. DOI: 10.1186/2051-1426-2-S3-P241 |
0.486 |
|
2014 |
Yopp A, Kallinteris N, Huang X, Shan J, Menander K, Hutchins J, King S, Xu X, Gabrilovich D, Brekken R. Correlative studies of a Phase II clinical study of bavituximab and sorafenib in patients with advanced hepatocellular carcinoma Journal For Immunotherapy of Cancer. 2: P214. DOI: 10.1186/2051-1426-2-S3-P214 |
0.386 |
|
2014 |
Ramachandran IR, Lin C, Chase T, Gabrilovich D, Nefedova Y. A Novel Agent Tasquinimod Demonstrates a Potent Anti-Tumor Activity in Pre-Clinical Models of Multiple Myeloma Blood. 124: 5729-5729. DOI: 10.1182/Blood.V124.21.5729.5729 |
0.487 |
|
2014 |
Ramachandran I, Condamine T, Gabrilovich D, Nefedova Y. Abstract 164: Bone marrow myeloid cells promote multiple myeloma chemoresistance by DNA mediated signaling Cancer Research. 74: 164-164. DOI: 10.1158/1538-7445.Am2014-164 |
0.518 |
|
2014 |
Mohammadyani D, Tyurin VA, Amoscato AA, Gabrilovich DI, Klein-Seetharaman J, Kagan VE. Computational Approaches to Understanding the Role of Oxidized Tri-Aclyglycerols in Suppression of Antigen Cross-Presentation in Cancer Biophysical Journal. 106: 805a-806a. DOI: 10.1016/J.Bpj.2013.11.4416 |
0.368 |
|
2014 |
Condamine T, Ramachandran IR, Gabrilovich DI. S100A9, inflammation, and regulation of immune suppression in cancer Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal. 295-310. DOI: 10.1007/978-1-4899-8056-4_10 |
0.45 |
|
2014 |
Gabrilovich DI, Hurwitz AA. Tumor-induced immune suppression: Mechanisms and therapeutic reversal Tumor-Induced Immune Suppression: Mechanisms and Therapeutic Reversal. 1-464. DOI: 10.1007/978-1-4899-8056-4 |
0.346 |
|
2013 |
Chen X, Eksioglu EA, Zhou J, Zhang L, Djeu J, Fortenbery N, Epling-Burnette P, Van Bijnen S, Dolstra H, Cannon J, Youn JI, Donatelli SS, Qin D, De Witte T, Tao J, ... ... Gabrilovich DI, et al. Induction of myelodysplasia by myeloid-derived suppressor cells. The Journal of Clinical Investigation. 123: 4595-611. PMID 24216507 DOI: 10.1172/Jci67580 |
0.668 |
|
2013 |
Talmadge JE, Gabrilovich DI. History of myeloid-derived suppressor cells. Nature Reviews. Cancer. 13: 739-52. PMID 24060865 DOI: 10.1038/Nrc3581 |
0.479 |
|
2013 |
Liu H, Zhou J, Cheng P, Ramachandran I, Nefedova Y, Gabrilovich DI. Regulation of dendritic cell differentiation in bone marrow during emergency myelopoiesis. Journal of Immunology (Baltimore, Md. : 1950). 191: 1916-26. PMID 23833236 DOI: 10.4049/Jimmunol.1300714 |
0.407 |
|
2013 |
Nagaraj S, Youn JI, Gabrilovich DI. Reciprocal relationship between myeloid-derived suppressor cells and T cells. Journal of Immunology (Baltimore, Md. : 1950). 191: 17-23. PMID 23794702 DOI: 10.4049/Jimmunol.1300654 |
0.735 |
|
2013 |
Iclozan C, Antonia S, Chiappori A, Chen DT, Gabrilovich D. Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer. Cancer Immunology, Immunotherapy : Cii. 62: 909-18. PMID 23589106 DOI: 10.1007/S00262-013-1396-8 |
0.413 |
|
2013 |
Youn JI, Gabrilovich DI. New roles of Rb1 in expansion of MDSCs in cancer. Cell Cycle (Georgetown, Tex.). 12: 1329-30. PMID 23588070 DOI: 10.4161/Cc.24577 |
0.751 |
|
2013 |
Ramachandran IR, Martner A, Pisklakova A, Condamine T, Chase T, Vogl T, Roth J, Gabrilovich D, Nefedova Y. Myeloid-derived suppressor cells regulate growth of multiple myeloma by inhibiting T cells in bone marrow. Journal of Immunology (Baltimore, Md. : 1950). 190: 3815-23. PMID 23460744 DOI: 10.4049/Jimmunol.1203373 |
0.483 |
|
2013 |
Gabrilovich DI. Applying pressure on macrophages. Immunity. 38: 205-6. PMID 23438819 DOI: 10.1016/J.Immuni.2013.02.004 |
0.371 |
|
2013 |
Ramakrishnan R, Gabrilovich DI. Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer. Cancer Immunology, Immunotherapy : Cii. 62: 405-10. PMID 23423351 DOI: 10.1007/S00262-012-1390-6 |
0.344 |
|
2013 |
Wang D, Yu Y, Haarberg K, Fu J, Kaosaard K, Nagaraj S, Anasetti C, Gabrilovich D, Yu XZ. Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 19: 692-702. PMID 23376089 DOI: 10.1016/J.Bbmt.2013.01.008 |
0.474 |
|
2013 |
Youn JI, Kumar V, Collazo M, Nefedova Y, Condamine T, Cheng P, Villagra A, Antonia S, McCaffrey JC, Fishman M, Sarnaik A, Horna P, Sotomayor E, Gabrilovich DI. Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. Nature Immunology. 14: 211-20. PMID 23354483 DOI: 10.1038/Ni.2526 |
0.698 |
|
2013 |
Ramakrishnan R, Gabrilovich DI. The role of mannose-6-phosphate receptor and autophagy in influencing the outcome of combination therapy. Autophagy. 9: 615-6. PMID 23324210 DOI: 10.4161/Auto.23485 |
0.43 |
|
2013 |
Gabrilovich D. Abstract IA7: Regulation of myeloid-derived suppressor cells in tumor micro-environment. Cancer Research. 73. DOI: 10.1158/1538-7445.Tumimm2012-Ia7 |
0.593 |
|
2013 |
Youn J, Kumar V, Collazo M, Gabrilovich DI. Abstract 1515: Epigenetic silencing of retinoblastoma gene regulates pathologic differentiation of myeloid cells in cancer. Cancer Research. 73: 1515-1515. DOI: 10.1158/1538-7445.Am2013-1515 |
0.707 |
|
2012 |
Ramakrishnan R, Huang C, Cho HI, Lloyd M, Johnson J, Ren X, Altiok S, Sullivan D, Weber J, Celis E, Gabrilovich DI. Autophagy induced by conventional chemotherapy mediates tumor cell sensitivity to immunotherapy. Cancer Research. 72: 5483-93. PMID 22942258 DOI: 10.1158/0008-5472.Can-12-2236 |
0.509 |
|
2012 |
Lu T, Gabrilovich DI. Molecular pathways: tumor-infiltrating myeloid cells and reactive oxygen species in regulation of tumor microenvironment. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 4877-82. PMID 22718858 DOI: 10.1158/1078-0432.Ccr-11-2939 |
0.583 |
|
2012 |
Finkelstein SE, Rodriguez F, Dunn M, Farmello MJ, Smilee R, Janssen W, Kang L, Chuang T, Seigne J, Pow-Sang J, Torres-Roca JF, Heysek R, Biagoli M, Shankar R, Scott J, ... ... Gabrilovich D, et al. Serial assessment of lymphocytes and apoptosis in the prostate during coordinated intraprostatic dendritic cell injection and radiotherapy. Immunotherapy. 4: 373-82. PMID 22512631 DOI: 10.2217/Imt.12.24 |
0.444 |
|
2012 |
Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nature Reviews. Immunology. 12: 253-68. PMID 22437938 DOI: 10.1038/Nri3175 |
0.488 |
|
2012 |
Finkelstein SE, Fishman M, Conley AP, Gabrilovich D, Antonia S, Chiappori A. Cellular immunotherapy for soft tissue sarcomas. Immunotherapy. 4: 283-90. PMID 22401634 DOI: 10.2217/Imt.12.3 |
0.324 |
|
2012 |
Nagaraj S, Gabrilovich DI. Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells. Seminars in Cancer Biology. 22: 282-8. PMID 22313876 DOI: 10.1016/J.Semcancer.2012.01.010 |
0.454 |
|
2012 |
Nagaraj S, Nelson A, Youn JI, Cheng P, Quiceno D, Gabrilovich DI. Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling. Cancer Research. 72: 928-38. PMID 22237629 DOI: 10.1158/0008-5472.Can-11-2863 |
0.69 |
|
2012 |
Huang C, Ramakrishnan R, Trkulja M, Ren X, Gabrilovich DI. Therapeutic effect of intratumoral administration of DCs with conditional expression of combination of different cytokines. Cancer Immunology, Immunotherapy : Cii. 61: 573-9. PMID 22223258 DOI: 10.1007/S00262-011-1198-9 |
0.478 |
|
2012 |
Youn JI, Collazo M, Shalova IN, Biswas SK, Gabrilovich DI. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. Journal of Leukocyte Biology. 91: 167-81. PMID 21954284 DOI: 10.1189/Jlb.0311177 |
0.678 |
|
2012 |
Finkelstein SE, Iclozan C, Bui MM, Cotter MJ, Ramakrishnan R, Ahmed J, Noyes DR, Cheong D, Gonzalez RJ, Heysek RV, Berman C, Lenox BC, Janssen W, Zager JS, Sondak VK, ... ... Gabrilovich DI, et al. Combination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients International Journal of Radiation Oncology Biology Physics. 82: 924-932. PMID 21398051 DOI: 10.1016/J.Ijrobp.2010.12.068 |
0.514 |
|
2012 |
Iclozan C, Gabrilovich DI. Recent Advances in Immunotherapy of Lung Cancer Journal of Lung Cancer. 11: 1. DOI: 10.6058/Jlc.2012.11.1.1 |
0.344 |
|
2012 |
Sahakian E, Powers J, Horna P, Rock-Klotz J, Deng S, Woods DM, Nguyen M, Woan KV, Cheng F, Villagra A, Gabrilovich D, Sotomayor EM, Pinilla-Ibarz J. Novel Role of Histone Deacetylase 11 (HDAC11) in Hematopoiesis Blood. 120: 4728-4728. DOI: 10.1182/Blood.V120.21.4728.4728 |
0.432 |
|
2012 |
Ramachandran IR, Martner A, Condamine TC, Pisklakova A, Chase T, Gabrilovich D, Nefedova Y. Accumulation of Myeloid-Derived Suppressor Cells in Bone Marrow in Multiple Myeloma Induces Tumor-Specific Immune Suppression and Promotes Tumor Growth Blood. 120: 3954-3954. DOI: 10.1182/Blood.V120.21.3954.3954 |
0.55 |
|
2012 |
Wang D, Yu Y, Semple KM, Haarberg KM, Fu J, Kaosaard K, Anasetti C, Srinivas N, Gabrilovich D, Yu X. Dynamic Changes and Impact of Myeloid Derived Suppressor Cells in Allogeneic Bone Marrow Transplantation in Mice. Blood. 120: 2999-2999. DOI: 10.1182/Blood.V120.21.2999.2999 |
0.451 |
|
2012 |
Youn J, Collazo M, Kumar V, Gabrilovich DI. Abstract 5411: Rb1 controls the differentiation of myeloid-derived suppressor cells subsets Immunology. 72: 5411-5411. DOI: 10.1158/1538-7445.Am2012-5411 |
0.638 |
|
2012 |
Condamine T, Cheng P, Youn J, Ortiz ML, Vogl T, Roth J, Gabrilovich DI. Abstract 5399: S100A9 drives MDSC migration and contributes to tumor progression by inhibiting the immune response Cancer Research. 72: 5399-5399. DOI: 10.1158/1538-7445.Am2012-5399 |
0.737 |
|
2012 |
Cao W, Koomen JM, Gabrilovich DI, Tyurin VA, Kagan VE. Abstract 3530: Lipid accumulation inhibits DC ability for cross-presentation of antigens in tumor-bearing mice Cancer Research. 72: 3530-3530. DOI: 10.1158/1538-7445.Am2012-3530 |
0.467 |
|
2012 |
Gabrilovich D, Ramakrishnan R, Huang C. Abstract IA18: Molecular mechanisms regulating synergistic effect of immunotherapy and chemotherapy of cancer Clinical Cancer Research. 18: IA18-IA18. DOI: 10.1158/1078-0432.12Aacriaslc-Ia18 |
0.55 |
|
2011 |
Finkelstein SE, Gabrilovich D, Rodriguez FA, Chuang T, Kang L, Torres-Roca J, Heysek R, Pow-Sang JM, Antonia S, Fishman MN. Know when to say when: Serial assessment of apoptosis and lymphocyte infiltrates with combined intraprostatic autologous dendritic cell immunotherapy/radiation therapy in high-risk prostate cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 149. PMID 27968604 DOI: 10.1200/Jco.2011.29.7_Suppl.149 |
0.487 |
|
2011 |
Medzhitov R, Shevach EM, Trinchieri G, Mellor AL, Munn DH, Gordon S, Libby P, Hansson GK, Shortman K, Dong C, Gabrilovich D, Gabryšová L, Howes A, O'Garra A. Highlights of 10 years of immunology in Nature Reviews Immunology. Nature Reviews. Immunology. 11: 693-702. PMID 21941295 DOI: 10.1038/Nri3063 |
0.405 |
|
2011 |
Lu T, Ramakrishnan R, Altiok S, Youn JI, Cheng P, Celis E, Pisarev V, Sherman S, Sporn MB, Gabrilovich D. Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice. The Journal of Clinical Investigation. 121: 4015-29. PMID 21911941 DOI: 10.1172/Jci45862 |
0.725 |
|
2011 |
Tyurin VA, Cao W, Tyurina YY, Gabrilovich DI, Kagan VE. Mass-spectrometric characterization of peroxidized and hydrolyzed lipids in plasma and dendritic cells of tumor-bearing animals. Biochemical and Biophysical Research Communications. 413: 149-53. PMID 21872574 DOI: 10.1016/J.Bbrc.2011.08.074 |
0.536 |
|
2011 |
Cao M, Xu Y, Youn JI, Cabrera R, Zhang X, Gabrilovich D, Nelson DR, Liu C. Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model. Laboratory Investigation; a Journal of Technical Methods and Pathology. 91: 598-608. PMID 21321535 DOI: 10.1038/Labinvest.2010.205 |
0.717 |
|
2011 |
Condamine T, Gabrilovich DI. Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends in Immunology. 32: 19-25. PMID 21067974 DOI: 10.1016/J.It.2010.10.002 |
0.54 |
|
2011 |
Ramakrishnan R, Gabrilovich DI. Mechanism of synergistic effect of chemotherapy and immunotherapy of cancer. Cancer Immunology, Immunotherapy : Cii. 60: 419-23. PMID 20976448 DOI: 10.1007/S00262-010-0930-1 |
0.359 |
|
2011 |
Wei S, Chen X, Zhou J, Zhang L, Fortenbery NR, Rasche SS, McGraw K, Eksioglu EA, Epling-Burnette P, Djeu JY, Gabrilovich DI, List AF. Microenvironment Induced Myelodysplastic Syndrome (MDS) in S100A9 Transgenic Mice Caused by Myeloid-Derived Suppressor Cells (MDSC) Blood. 118: 788-788. DOI: 10.1182/Blood.V118.21.788.788 |
0.419 |
|
2011 |
Cao W, Gabrilovich D. Abstract 3649: Contribution of fatty acid accumulation to myeloid-derived suppressor cell function in cancer Cancer Research. 71: 3649-3649. DOI: 10.1158/1538-7445.Am2011-3649 |
0.541 |
|
2011 |
Condamine T, Cheng P, Youn J, Ortiz ML, Vogl T, Roth J, Gabrilovich DI. Abstract 3648: S100A9 play a role in MDSC expansion and migration but not in their activation Cancer Research. 71: 3648-3648. DOI: 10.1158/1538-7445.Am2011-3648 |
0.747 |
|
2011 |
Youn J, Collazo MM, Gabrilovich D. Abstract 3647: Characterization of the relationship between mature neutrophils and tumor associated granulocytic myeloid-derived suppressor cells Cancer Research. 71: 3647-3647. DOI: 10.1158/1538-7445.Am2011-3647 |
0.669 |
|
2011 |
Ortiz ML, Cheng P, Luetteke N, Youn J, Gabrilovich DI. Abstract 3646: The role of myeloid-derived suppressor cells in tumor development Cancer Research. 71: 3646-3646. DOI: 10.1158/1538-7445.Am2011-3646 |
0.671 |
|
2011 |
Talmadge JE, Gabrilovich DI. Conference on regulatory myeloid cells International Immunopharmacology. 11: 779. DOI: 10.1016/j.intimp.2011.04.009 |
0.359 |
|
2010 |
Li M, Chen F, Clifton N, Sullivan DM, Dalton WS, Gabrilovich DI, Nefedova Y. Combined inhibition of Notch signaling and Bcl-2/Bcl-xL results in synergistic antimyeloma effect. Molecular Cancer Therapeutics. 9: 3200-9. PMID 21159606 DOI: 10.1158/1535-7163.Mct-10-0372 |
0.41 |
|
2010 |
Youn JI, Gabrilovich DI. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. European Journal of Immunology. 40: 2969-75. PMID 21061430 DOI: 10.1002/Eji.201040895 |
0.716 |
|
2010 |
Corzo CA, Condamine T, Lu L, Cotter MJ, Youn JI, Cheng P, Cho HI, Celis E, Quiceno DG, Padhya T, McCaffrey TV, McCaffrey JC, Gabrilovich DI. HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. The Journal of Experimental Medicine. 207: 2439-53. PMID 20876310 DOI: 10.1084/Jem.20100587 |
0.808 |
|
2010 |
Finkelstein SE, Carey T, Fricke I, Yu D, Goetz D, Gratz M, Dunn M, Urbas P, Daud A, DeConti R, Antonia S, Gabrilovich D, Fishman M. Changes in dendritic cell phenotype after a new high-dose weekly schedule of interleukin-2 therapy for kidney cancer and melanoma. Journal of Immunotherapy (Hagerstown, Md. : 1997). 33: 817-27. PMID 20842055 DOI: 10.1097/Cji.0B013E3181Ecccad |
0.315 |
|
2010 |
Nagaraj S, Gabrilovich DI. Myeloid-derived suppressor cells in human cancer. Cancer Journal (Sudbury, Mass.). 16: 348-53. PMID 20693846 DOI: 10.1097/Ppo.0B013E3181Eb3358 |
0.49 |
|
2010 |
Herber DL, Cao W, Nefedova Y, Novitskiy SV, Nagaraj S, Tyurin VA, Corzo A, Cho HI, Celis E, Lennox B, Knight SC, Padhya T, McCaffrey TV, McCaffrey JC, Antonia S, ... ... Gabrilovich DI, et al. Lipid accumulation and dendritic cell dysfunction in cancer. Nature Medicine. 16: 880-6. PMID 20622859 DOI: 10.1038/Nm.2172 |
0.464 |
|
2010 |
Chiappori AA, Soliman H, Janssen WE, Antonia SJ, Gabrilovich DI. INGN-225: a dendritic cell-based p53 vaccine (Ad.p53-DC) in small cell lung cancer: observed association between immune response and enhanced chemotherapy effect. Expert Opinion On Biological Therapy. 10: 983-91. PMID 20420527 DOI: 10.1517/14712598.2010.484801 |
0.466 |
|
2010 |
Ramakrishnan R, Assudani D, Nagaraj S, Hunter T, Cho HI, Antonia S, Altiok S, Celis E, Gabrilovich DI. Chemotherapy enhances tumor cell susceptibility to CTL-mediated killing during cancer immunotherapy in mice. The Journal of Clinical Investigation. 120: 1111-24. PMID 20234093 DOI: 10.1172/Jci40269 |
0.536 |
|
2010 |
Nagaraj S, Youn JI, Weber H, Iclozan C, Lu L, Cotter MJ, Meyer C, Becerra CR, Fishman M, Antonia S, Sporn MB, Liby KT, Rawal B, Lee JH, Gabrilovich DI. Anti-inflammatory triterpenoid blocks immune suppressive function of MDSCs and improves immune response in cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 1812-23. PMID 20215551 DOI: 10.1158/1078-0432.Ccr-09-3272 |
0.703 |
|
2010 |
Cheng P, Zhou J, Gabrilovich D. Regulation of dendritic cell differentiation and function by Notch and Wnt pathways. Immunological Reviews. 234: 105-19. PMID 20193015 DOI: 10.1111/J.0105-2896.2009.00871.X |
0.422 |
|
2010 |
Nagaraj S, Schrum AG, Cho HI, Celis E, Gabrilovich DI. Mechanism of T cell tolerance induced by myeloid-derived suppressor cells. Journal of Immunology (Baltimore, Md. : 1950). 184: 3106-16. PMID 20142361 DOI: 10.4049/Jimmunol.0902661 |
0.433 |
|
2010 |
Ramakrishnan R, Assudani D, Celis E, Gabrilovich D. Abstract 5599: Novel mechanism of synergistic effect of cancer immunotherapy and chemotherapy Cancer Research. 70: 5599-5599. DOI: 10.1158/1538-7445.Am10-5599 |
0.575 |
|
2010 |
Iclozan C, Finkelstein SE, Ahmed J, Bui MM, Cotter MJ, Ramakrishnan R, Cheong D, Gonzalez RJ, Heysek RV, Lenox BC, Sondak VK, Szekely RR, Zager JS, Letson GD, Antonia SJ, ... Gabrilovich DI, et al. Abstract 2411: Intratumoral dendritic cell vaccine as neo-adjuvant immunotherapy of high-risk soft tissue sarcoma patients undergoing external beam radiation therapy (EBRT): Prospective phase I/II clinical trial Cancer Research. 70: 2411-2411. DOI: 10.1158/1538-7445.Am10-2411 |
0.494 |
|
2010 |
Iclozan C, Cotter M, Ramakrishnan R, Lenox B, Bui M, Letson G, Antonia S, Gabrilovich D, Finkelstein S. Myeloid-derived Suppressor Cell and Regulatory T Cell Immune Monitoring of Soft Tissue Sarcoma Patients Undergoing Combination External Beam Radiation and Intratumoral Dendritic Cell Vaccination International Journal of Radiation Oncology*Biology*Physics. 78: S657-S658. DOI: 10.1016/J.Ijrobp.2010.07.1530 |
0.429 |
|
2009 |
Nagaraj S, Collazo M, Corzo CA, Youn JI, Ortiz M, Quiceno D, Gabrilovich DI. Regulatory myeloid suppressor cells in health and disease. Cancer Research. 69: 7503-6. PMID 19752086 DOI: 10.1158/0008-5472.Can-09-2152 |
0.769 |
|
2009 |
Zhou J, Cheng P, Youn JI, Cotter MJ, Gabrilovich DI. Notch and wingless signaling cooperate in regulation of dendritic cell differentiation. Immunity. 30: 845-59. PMID 19523851 DOI: 10.1016/J.Immuni.2009.03.021 |
0.621 |
|
2009 |
Corzo CA, Cotter MJ, Cheng P, Cheng F, Kusmartsev S, Sotomayor E, Padhya T, McCaffrey TV, McCaffrey JC, Gabrilovich DI. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. Journal of Immunology (Baltimore, Md. : 1950). 182: 5693-701. PMID 19380816 DOI: 10.4049/Jimmunol.0900092 |
0.764 |
|
2009 |
Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nature Reviews. Immunology. 9: 162-74. PMID 19197294 DOI: 10.1038/Nri2506 |
0.532 |
|
2009 |
Gabrilovich D. Mechanism of Myeloid-Derived Suppressor Cell Differentiation in Cancer. Blood. 114: SCI-31-SCI-31. DOI: 10.1182/Blood.V114.22.Sci-31.Sci-31 |
0.559 |
|
2009 |
Wei S, Chen X, Rocha K, Qi D, Tao J, Gjertsen N, Zhou J, Liu J, Gabrilovich D, Epling-Burnette PK, Djeu JY, List AF. Myeloid-Derived Suppressor Cells (MDSC) Are Effectors of Bone Marrow Suppression in Lower Risk Myelodysplastic Syndromes (MDS). Blood. 114: 597-597. DOI: 10.1182/Blood.V114.22.597.597 |
0.352 |
|
2009 |
Ahmed I, Gabrilovich D, Cheong D, Gonzalez R, Heysek R, Johnson D, Sondak V, Letson G, Antonia S, Finkelstein S. Novel Image Guided Visualization of Experimental Cellular-based Vaccines, In Vivo, during Combined Radiation/Immunotherapy Protocols International Journal of Radiation Oncology*Biology*Physics. 75: S564. DOI: 10.1016/J.Ijrobp.2009.07.1289 |
0.305 |
|
2009 |
Gabrilovich DI. A role for STAT3 in dendritic cell regulation by tumor-derived factors Dendritic Cells in Cancer. 143-155. DOI: 10.1007/978-0-387-88611-4_10 |
0.445 |
|
2008 |
Nefedova Y, Gabrilovich D. Mechanisms and clinical prospects of Notch inhibitors in the therapy of hematological malignancies. Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy. 11: 210-8. PMID 18951834 DOI: 10.1016/J.Drup.2008.09.002 |
0.354 |
|
2008 |
Youn JI, Nagaraj S, Collazo M, Gabrilovich DI. Subsets of myeloid-derived suppressor cells in tumor-bearing mice. Journal of Immunology (Baltimore, Md. : 1950). 181: 5791-802. PMID 18832739 DOI: 10.4049/Jimmunol.181.8.5791 |
0.727 |
|
2008 |
Cheng P, Corzo CA, Luetteke N, Yu B, Nagaraj S, Bui MM, Ortiz M, Nacken W, Sorg C, Vogl T, Roth J, Gabrilovich DI. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. The Journal of Experimental Medicine. 205: 2235-49. PMID 18809714 DOI: 10.1084/Jem.20080132 |
0.757 |
|
2008 |
Daud AI, Mirza N, Lenox B, Andrews S, Urbas P, Gao GX, Lee JH, Sondak VK, Riker AI, Deconti RC, Gabrilovich D. Phenotypic and functional analysis of dendritic cells and clinical outcome in patients with high-risk melanoma treated with adjuvant granulocyte macrophage colony-stimulating factor. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3235-41. PMID 18591558 DOI: 10.1200/Jco.2007.13.9048 |
0.343 |
|
2008 |
Ramakrishnan R, Antonia S, Gabrilovich DI. Combined modality immunotherapy and chemotherapy: a new perspective. Cancer Immunology, Immunotherapy : Cii. 57: 1523-9. PMID 18488219 DOI: 10.1007/S00262-008-0531-4 |
0.452 |
|
2008 |
Nagaraj S, Gabrilovich DI. Tumor escape mechanism governed by myeloid-derived suppressor cells. Cancer Research. 68: 2561-3. PMID 18413722 DOI: 10.1158/0008-5472.Can-07-6229 |
0.52 |
|
2008 |
Nefedova Y, Sullivan DM, Bolick SC, Dalton WS, Gabrilovich DI. Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy. Blood. 111: 2220-9. PMID 18039953 DOI: 10.1182/Blood-2007-07-102632 |
0.405 |
|
2008 |
Cheng P, Gabrilovich D. Notch signaling in differentiation and function of dendritic cells. Immunologic Research. 41: 1-14. PMID 18008056 DOI: 10.1007/s12026-007-8011-z |
0.354 |
|
2008 |
Hazlehurst L, Dalton WS, Yarde D, Nefedova Y, Gabrilovich D. Influence of Targeted Therapy in Redefining High-Risk Myeloma. Blood. 112: sci-7-sci-7. DOI: 10.1182/Blood.V112.11.Sci-7.Sci-7 |
0.38 |
|
2008 |
Gabrilovich DI, Hurwitz AA. Tumor induced immune suppression: Mechanisms and therapeutic reversal Tumor Induced Immune Suppression: Mechanisms and Therapeutic Reversal. 1-301. DOI: 10.1007/978-0-387-69118-3 |
0.346 |
|
2007 |
Nefedova Y, Fishman M, Sherman S, Wang X, Beg AA, Gabrilovich DI. Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells. Cancer Research. 67: 11021-8. PMID 18006848 DOI: 10.1158/0008-5472.Can-07-2593 |
0.574 |
|
2007 |
Nagaraj S, Gabrilovich DI. Myeloid-derived suppressor cells. Advances in Experimental Medicine and Biology. 601: 213-23. PMID 17713008 DOI: 10.1007/978-0-387-72005-0_22 |
0.548 |
|
2007 |
Fricke I, Mirza N, Dupont J, Lockhart C, Jackson A, Lee JH, Sosman JA, Gabrilovich DI. Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 4840-8. PMID 17699863 DOI: 10.1158/1078-0432.Ccr-07-0409 |
0.518 |
|
2007 |
Nagaraj S, Gupta K, Pisarev V, Kinarsky L, Sherman S, Kang L, Herber DL, Schneck J, Gabrilovich DI. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nature Medicine. 13: 828-35. PMID 17603493 DOI: 10.1038/Nm1609 |
0.437 |
|
2007 |
Delano MJ, Scumpia PO, Weinstein JS, Coco D, Nagaraj S, Kelly-Scumpia KM, O'Malley KA, Wynn JL, Antonenko S, Al-Quran SZ, Swan R, Chung CS, Atkinson MA, Ramphal R, Gabrilovich DI, et al. MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. The Journal of Experimental Medicine. 204: 1463-74. PMID 17548519 DOI: 10.1084/Jem.20062602 |
0.471 |
|
2007 |
Herber DL, Nagaraj S, Djeu JY, Gabrilovich DI. Mechanism and therapeutic reversal of immune suppression in cancer. Cancer Research. 67: 5067-9. PMID 17545581 DOI: 10.1158/0008-5472.Can-07-0897 |
0.459 |
|
2007 |
Nagaraj S, Pisarev V, Kinarsky L, Sherman S, Muro-Cacho C, Altieri DC, Gabrilovich DI. Dendritic cell-based full-length survivin vaccine in treatment of experimental tumors. Journal of Immunotherapy (Hagerstown, Md. : 1997). 30: 169-79. PMID 17471164 DOI: 10.1097/01.Cji.0000211329.83890.Ba |
0.562 |
|
2007 |
Mirza N, Gabrilovich D. Comment on "Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells". Journal of Immunology. 178: 4705-4706. PMID 17404244 DOI: 10.4049/Jimmunol.178.8.4705-A |
0.36 |
|
2007 |
Nefedova Y, Gabrilovich DI. Targeting of Jak/STAT pathway in antigen presenting cells in cancer. Current Cancer Drug Targets. 7: 71-7. PMID 17305479 DOI: 10.2174/156800907780006887 |
0.54 |
|
2007 |
Gabrilovich DI, Bronte V, Chen SH, Colombo MP, Ochoa A, Ostrand-Rosenberg S, Schreiber H. The terminology issue for myeloid-derived suppressor cells. Cancer Research. 67: 425; author reply 42. PMID 17210725 DOI: 10.1158/0008-5472.Can-06-3037 |
0.408 |
|
2007 |
Gabrilovich DI. Combination of chemotherapy and immunotherapy for cancer: a paradigm revisited. The Lancet. Oncology. 8: 2-3. PMID 17196504 DOI: 10.1016/S1470-2045(06)70985-8 |
0.337 |
|
2007 |
Rabinovich GA, Gabrilovich D, Sotomayor EM. Immunosuppressive strategies that are mediated by tumor cells. Annual Review of Immunology. 25: 267-96. PMID 17134371 DOI: 10.1146/Annurev.Immunol.25.022106.141609 |
0.551 |
|
2007 |
Cheng P, Nefedova Y, Corzo CA, Gabrilovich DI. Regulation of dendritic-cell differentiation by bone marrow stroma via different Notch ligands. Blood. 109: 507-15. PMID 16973960 DOI: 10.1182/Blood-2006-05-025601 |
0.66 |
|
2007 |
Chiappori A, Sereno M, Gabrilovich D, Mirza N, Dunn M, Janssen W, Smilee R, Menander K, Chada S, Antonia S. Phase II trial of patients (pts) with extensive stage small cell lung cancer (ES-SCLC) immunized with p53-transduced dendritic cells (p53-DC): Immune sensitization to chemotherapy (CT) Journal of Clinical Oncology. 25: 3012-3012. DOI: 10.1200/Jco.2007.25.18_Suppl.3012 |
0.34 |
|
2007 |
Sosman JA, Fricke I, Mirza N, Dupont J, Lockhart AC, Jackson A, LaFleur B, Gabrilovich D. VEGF-Trap (V-T) overcomes defects in dendritic cell (DC) differentiation without improvement in antigen-specific immune responses Journal of Clinical Oncology. 25: 21087-21087. DOI: 10.1200/Jco.2007.25.18_Suppl.21087 |
0.452 |
|
2007 |
Antonia S, Mirza N, Chiappori A, Fricke I, Bepler G, Simon G, Janssen W, Lee J, Menander K, Chada S, Gabrilovich DI. M17-02: Immunotherapy of extensive stage small cell lung cancer with dendritic cell based p53 vaccine Journal of Thoracic Oncology. 2: S198-S199. DOI: 10.1097/01.Jto.0000282976.88618.Ff |
0.38 |
|
2007 |
Gabrilovich D, Nagaraj S, Gupta K, Schneck J. Evaluation of antigen binding by CD8+ T cells after in vivo treatment with myeloid derived suppressor cells Nature Protocols. DOI: 10.1038/Nprot.2007.240 |
0.418 |
|
2007 |
Nagaraj S, Gabrilovich D. Evaluation of nitrotyrosine expression on the surface of CD8+ T cells Nature Protocols. DOI: 10.1038/Nprot.2007.239 |
0.332 |
|
2006 |
Kusmartsev S, Gabrilovich DI. Effect of tumor-derived cytokines and growth factors on differentiation and immune suppressive features of myeloid cells in cancer. Cancer Metastasis Reviews. 25: 323-31. PMID 16983515 DOI: 10.1007/S10555-006-9002-6 |
0.571 |
|
2006 |
Mirza N, Fishman M, Fricke I, Dunn M, Neuger AM, Frost TJ, Lush RM, Antonia S, Gabrilovich DI. All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients. Cancer Research. 66: 9299-307. PMID 16982775 DOI: 10.1158/0008-5472.Can-06-1690 |
0.485 |
|
2006 |
Fricke I, Gabrilovich DI. Dendritic cells and tumor microenvironment: a dangerous liaison. Immunological Investigations. 35: 459-83. PMID 16916762 DOI: 10.1080/08820130600803429 |
0.548 |
|
2006 |
Antonia SJ, Mirza N, Fricke I, Chiappori A, Thompson P, Williams N, Bepler G, Simon G, Janssen W, Lee JH, Menander K, Chada S, Gabrilovich DI. Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 878-87. PMID 16467102 DOI: 10.1158/1078-0432.Ccr-05-2013 |
0.39 |
|
2006 |
Kusmartsev S, Gabrilovich DI. Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunology, Immunotherapy : Cii. 55: 237-45. PMID 16047143 DOI: 10.1007/S00262-005-0048-Z |
0.594 |
|
2006 |
Nefedova Y, Verali K, Sullivan DM, Dalton WS, Gabrilovich DI. A New Target in Multiple Myeloma: Inhibition of Notch Pathway Induces Apoptosis and Enhances Drug Sensitivity of Myeloma Cells In Vitro and In Vivo. Blood. 108: 841-841. DOI: 10.1182/Blood.V108.11.841.841 |
0.48 |
|
2005 |
Gabrilovich DI, Mirza N, Chiappori A, Dunn M, Willis M, Janssen W, Smilee R, Menander K, Chada S, Antonia S. Initial results of a phase II trial of patients with extensive stage small cell lung cancer (SCLC) immunized with dendritic cells (DC) transduced with wild-type p53. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 2543. PMID 27945832 DOI: 10.1200/Jco.2005.23.16_Suppl.2543 |
0.469 |
|
2005 |
Nefedova Y, Nagaraj S, Rosenbauer A, Muro-Cacho C, Sebti SM, Gabrilovich DI. Regulation of dendritic cell differentiation and antitumor immune response in cancer by pharmacologic-selective inhibition of the janus-activated kinase 2/signal transducers and activators of transcription 3 pathway. Cancer Research. 65: 9525-35. PMID 16230418 DOI: 10.1158/0008-5472.Can-05-0529 |
0.551 |
|
2005 |
Kusmartsev S, Nagaraj S, Gabrilovich DI. Tumor-associated CD8+ T cell tolerance induced by bone marrow-derived immature myeloid cells. Journal of Immunology (Baltimore, Md. : 1950). 175: 4583-92. PMID 16177103 DOI: 10.4049/Jimmunol.175.7.4583 |
0.545 |
|
2005 |
Nefedova Y, Cheng P, Gilkes D, Blaskovich M, Beg AA, Sebti SM, Gabrilovich DI. Activation of dendritic cells via inhibition of Jak2/STAT3 signaling. Journal of Immunology (Baltimore, Md. : 1950). 175: 4338-46. PMID 16177074 DOI: 10.4049/Jimmunol.175.7.4338 |
0.444 |
|
2005 |
Maroof A, English NR, Bedford PA, Gabrilovich DI, Knight SC. Developing dendritic cells become 'lacy' cells packed with fat and glycogen. Immunology. 115: 473-83. PMID 16011516 DOI: 10.1111/J.1365-2567.2005.02181.X |
0.418 |
|
2005 |
Plescia J, Salz W, Xia F, Pennati M, Zaffaroni N, Daidone MG, Meli M, Dohi T, Fortugno P, Nefedova Y, Gabrilovich DI, Colombo G, Altieri DC. Rational design of shepherdin, a novel anticancer agent. Cancer Cell. 7: 457-68. PMID 15894266 DOI: 10.1016/J.Ccr.2005.03.035 |
0.459 |
|
2005 |
Kusmartsev S, Gabrilovich DI. STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion. Journal of Immunology (Baltimore, Md. : 1950). 174: 4880-91. PMID 15814715 DOI: 10.4049/Jimmunol.174.8.4880 |
0.565 |
|
2005 |
Gabrilovich DI. The neutrophils: New outlook for old cells The Neutrophils: New Outlook For Old Cells. 1-355. DOI: 10.1142/P340 |
0.355 |
|
2005 |
Gabrilovich D, Nagaraj S, Kusmartsev S. Tumor Associated CD8+ T-Cell Tolerance Induced by Bone Marrow Derived Immature Myeloid Cells Journal of Immunotherapy. 28: 648. DOI: 10.1097/01.Cji.0000191065.34501.E3 |
0.464 |
|
2005 |
Mirza NN, Antonia SJ, Fricke I, Chiappori A, Thompson P, Williams N, Bepler G, Simon G, Janssen W, Menander K, Chada S, Gabrilovich DI. Effective Combination of Cancer Vaccine With Chemotherapy in Patients With Extensive Stage Lung Cancer Journal of Immunotherapy. 28: 612-613. DOI: 10.1097/01.Cji.0000190947.95008.45 |
0.306 |
|
2004 |
Cheng F, Gabrilovich D, Sotomayor EM. Immune tolerance in breast cancer. Breast Disease. 20: 93-103. PMID 15687711 DOI: 10.3233/Bd-2004-20111 |
0.456 |
|
2004 |
Gabrilovich DI. Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nature Reviews Immunology. 4: 941-952. PMID 15573129 DOI: 10.1038/Nri1498 |
0.454 |
|
2004 |
Kusmartsev S, Nefedova Y, Yoder D, Gabrilovich DI. Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species. Journal of Immunology (Baltimore, Md. : 1950). 172: 989-99. PMID 14707072 DOI: 10.4049/Jimmunol.172.2.989 |
0.531 |
|
2004 |
Wang T, Niu G, Kortylewski M, Burdelya L, Shain K, Zhang S, Bhattacharya R, Gabrilovich D, Heller R, Coppola D, Dalton W, Jove R, Pardoll D, Yu H. Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells. Nature Medicine. 10: 48-54. PMID 14702634 DOI: 10.1038/Nm976 |
0.564 |
|
2004 |
Nefedova Y, Huang M, Kusmartsev S, Bhattacharya R, Cheng P, Salup R, Jove R, Gabrilovich D. Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer. Journal of Immunology (Baltimore, Md. : 1950). 172: 464-74. PMID 14688356 DOI: 10.4049/Jimmunol.172.1.464 |
0.557 |
|
2004 |
Nefedova Y, Cheng P, Alsina M, Dalton WS, Gabrilovich DI. Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines. Blood. 103: 3503-10. PMID 14670925 DOI: 10.1182/Blood-2003-07-2340 |
0.462 |
|
2004 |
Wang T, Niu G, Kortylewski M, Burdelya L, Shain K, Zhang S, Bhattacharya R, Gabrilovich D, Heller R, Coppola D, Dalton W, Jove R, Pardoll D, Yu H. Erratum: Corrigendum: Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells Nature Medicine. 10: 209-209. DOI: 10.1038/Nm0204-209B |
0.403 |
|
2003 |
Gabrilovich D, Pisarev V. Tumor escape from immune response: mechanisms and targets of activity. Current Drug Targets. 4: 525-36. PMID 14535653 DOI: 10.2174/1389450033490849 |
0.533 |
|
2003 |
Kusmartsev S, Cheng F, Yu B, Nefedova Y, Sotomayor E, Lush R, Gabrilovich D. All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination. Cancer Research. 63: 4441-9. PMID 12907617 |
0.458 |
|
2003 |
Cheng P, Nefedova Y, Miele L, Osborne BA, Gabrilovich D. Notch signaling is necessary but not sufficient for differentiation of dendritic cells. Blood. 102: 3980-8. PMID 12907456 DOI: 10.1182/Blood-2003-04-1034 |
0.436 |
|
2003 |
Kusmartsev S, Gabrilovich DI. Inhibition of myeloid cell differentiation in cancer: the role of reactive oxygen species. Journal of Leukocyte Biology. 74: 186-96. PMID 12885935 DOI: 10.1189/Jlb.0103010 |
0.495 |
|
2003 |
Chada S, Mhashilkar A, Roth JA, Gabrilovich D. Development of vaccines against self-antigens: the p53 paradigm. Current Opinion in Drug Discovery & Development. 6: 169-73. PMID 12669451 |
0.354 |
|
2003 |
Ohm JE, Gabrilovich DI, Sempowski GD, Kisseleva E, Parman KS, Nadaf S, Carbone DP. VEGF inhibits T-cell development and may contribute to tumor-induced immune suppression. Blood. 101: 4878-86. PMID 12586633 DOI: 10.1182/Blood-2002-07-1956 |
0.447 |
|
2002 |
Gabrilovich DI. Dendritic cell vaccines for cancer treatment. Current Opinion in Molecular Therapeutics. 4: 452-8. PMID 12435046 |
0.444 |
|
2002 |
Gabrilovich DI, Cheng P, Fan Y, Yu B, Nikitina E, Sirotkin A, Shurin M, Oyama T, Adachi Y, Nadaf S, Carbone DP, Skoultchi AI. H1(0) histone and differentiation of dendritic cells. A molecular target for tumor-derived factors. Journal of Leukocyte Biology. 72: 285-96. PMID 12149419 |
0.364 |
|
2002 |
Kusmartsev S, Gabrilovich DI. Immature myeloid cells and cancer-associated immune suppression. Cancer Immunology, Immunotherapy : Cii. 51: 293-8. PMID 12111117 DOI: 10.1007/S00262-002-0280-8 |
0.558 |
|
2002 |
Keilholz U, Weber J, Finke JH, Gabrilovich DI, Kast WM, Disis ML, Kirkwood JM, Scheibenbogen C, Schlom J, Maino VC, Lyerly HK, Lee PP, Storkus W, Marincola F, Worobec A, et al. Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy. Journal of Immunotherapy (Hagerstown, Md. : 1997). 25: 97-138. PMID 12074049 DOI: 10.1097/00002371-200203000-00001 |
0.405 |
|
2002 |
Nikitina EY, Chada S, Muro-Cacho C, Fang B, Zhang R, Roth JA, Gabrilovich DI. An effective immunization and cancer treatment with activated dendritic cells transduced with full-length wild-type p53. Gene Therapy. 9: 345-52. PMID 11938454 DOI: 10.1038/Sj.Gt.3301670 |
0.485 |
|
2002 |
Gabrilovich DI, Cheng P, Fan Y, Yu B, Nikitina E, Sirotkin A, Shurin M, Oyama T, Adachi Y, Nadaf S, Carbone DP, Skoultchi AI. H1° histone and differentiation of dendritic cells. A molecular target for tumor-derived factors Journal of Leukocyte Biology. 72: 285-296. DOI: 10.1189/Jlb.72.2.285 |
0.509 |
|
2001 |
Gabrilovich D. Isolation of dendritic cells from mouse lymph nodes. Methods in Molecular Medicine. 64: 3-7. PMID 21374244 DOI: 10.1385/1-59259-150-7:3 |
0.312 |
|
2001 |
Nikitina E, Gabrilovich DI. Combination of γ-irradiation and dendritic cell administration induces a potent antitumor response in tumor-bearing mice: Approach to treatment of advanced stage cancer International Journal of Cancer. 94: 825-833. PMID 11745485 DOI: 10.1002/1097-0215(20011215)94:6<825::Aid-Ijc1545>3.0.Co;2-5 |
0.51 |
|
2001 |
Lisziewicz J, Gabrilovich DI, Varga G, Xu J, Greenberg PD, Arya SK, Bosch M, Behr JP, Lori F. Induction of potent human immunodeficiency virus type 1-specific T-cell-restricted immunity by genetically modified dendritic cells. Journal of Virology. 75: 7621-8. PMID 11462034 DOI: 10.1128/Jvi.75.16.7621-7628.2001 |
0.398 |
|
2001 |
Gabrilovich DI, Velders MP, Sotomayor EM, Kast WM. Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells Journal of Immunology. 166: 5398-5406. PMID 11313376 DOI: 10.4049/Jimmunol.166.9.5398 |
0.556 |
|
2001 |
Young MRI, Petruzzelli GJ, Kolesiak K, Achille N, Lathers DMR, Gabrilovich DI. Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34+ progenitor cells Human Immunology. 62: 332-341. PMID 11295465 DOI: 10.1016/S0198-8859(01)00222-1 |
0.416 |
|
2001 |
Nikitina EY, Clark JI, Van Beynen J, Chada S, Virmani AK, Carbone DP, Gabrilovich DI. Dendritic cells transduced with full-length wild-type p53 generate antitumor cytotoxic T lymphocytes from peripheral blood of cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 7: 127-35. PMID 11205900 |
0.346 |
|
2001 |
Almand B, Clark JI, Nikitina E, Van Beynen J, English NR, Knight SC, Carbone DP, Gabrilovich DI. Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer Journal of Immunology. 166: 678-689. PMID 11123353 DOI: 10.4049/Jimmunol.166.1.678 |
0.56 |
|
2001 |
Shurin MR, Gabrilovich DI. Regulation of dendritic cell system by tumor Cancer Research, Therapy and Control. 11: 65-78. |
0.442 |
|
2000 |
Almand B, Resser JR, Lindman B, Nadaf S, Clark JI, Kwon ED, Carbone DP, Gabrilovich DI. Clinical significance of defective dendritic cell differentiation in cancer Clinical Cancer Research. 6: 1755-1766. PMID 10815894 |
0.42 |
|
1999 |
Young MR, Kolesiak K, Wright MA, Gabrilovich DI. Chemoattraction of femoral CD34+ progenitor cells by tumor-derived vascular endothelial cell growth factor. Clinical & Experimental Metastasis. 17: 881-8. PMID 11089887 DOI: 10.1023/A:1006708607666 |
0.368 |
|
1999 |
Gabrilovich DI, Ishida T, Nadaf S, Ohm JE, Carbone DP. Antibodies to vascular endothelial growth factor enhance the efficacy of cancer immunotherapy by improving endogenous dendritic cell function Clinical Cancer Research. 5: 2963-2970. PMID 10537366 |
0.344 |
|
1998 |
Ishida T, Oyama T, Carbone DP, Gabrilovich DI. Defective function of langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors Journal of Immunology. 161: 4842-4851. PMID 9794417 |
0.397 |
|
1998 |
Gabrilovich D, Ishida T, Oyama T, Ran S, Kravtsov V, Nadaf S, Carbone DP. Vascular Endothelial Growth Factor Inhibits the Development of Dendritic Cells and Dramatically Affects the Differentiation of Multiple Hematopoietic Lineages In Vivo Blood. 92: 4150-4166. DOI: 10.1182/Blood.V92.11.4150.423K45_4150_4166 |
0.449 |
|
1997 |
Gabrilovich DI, Corak J, Ciernik IF, Kavanaugh D, Carbone DP. Decreased antigen presentation by dendritic cells in patients with breast cancer Clinical Cancer Research. 3: 483-490. PMID 9815709 |
0.376 |
|
1997 |
Gabrilovich D, Kavanaugh D, Ishida T, Ovama I, Lee CJ, Nadaf S, Sepetavec T, Jensen R, Gazdar A, Ciernik I, Corak J, Berzofsky J, Carbone DP. Induction of p53ras specific cellular immunity in patients with common solid tumors Lung Cancer. 18: 90-91. DOI: 10.1016/S0169-5002(97)83913-X |
0.446 |
|
1996 |
Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D, Carbone DP. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells Nature Medicine. 2: 1096-1103. PMID 8837607 DOI: 10.1038/Nm1096-1096 |
0.474 |
|
1996 |
Gabrilovich DI, Nadaf S, Corak J, Berzofsky JA, Carbone DP. Dendritic cells in antitumor immune responses II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors Cellular Immunology. 170: 111-119. PMID 8665591 DOI: 10.1006/cimm.1996.0140 |
0.424 |
|
1996 |
Gabrilovich DI, Ciernik IF, Carbone DP. Dendritic cells in antitumor immune responses I. Defective antigen presentation in tumor-bearing hosts Cellular Immunology. 170: 101-110. PMID 8665590 DOI: 10.1006/cimm.1996.0139 |
0.434 |
|
1996 |
Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, Kavanaugh D, Carbone DP. Erratum: Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells (Nature Medicine 2, 1096-1103 (1996)) Nature Medicine. 2. DOI: 10.1038/Nm1196-1267 |
0.374 |
|
1995 |
Woods GM, Gabrilovich DI, Elsley W, English N, Knight SC. Dendritic cells, apoptosis and murine retrovirus. Advances in Experimental Medicine and Biology. 378: 493-6. PMID 8526126 DOI: 10.1007/978-1-4615-1971-3_111 |
0.421 |
|
1994 |
Gabrilovich DI, Patterson S, Harvey JJ, Woods GM, Elsley W, Knight SC. Murine Retrovirus Induces Defects in the Function of Dendritic Cells at Early Stages of Infection Cellular Immunology. 158: 167-181. PMID 8087863 DOI: 10.1006/Cimm.1994.1265 |
0.35 |
|
1993 |
Gabrilovich DI, Roberts MS, Harvey JJ, Botcherby M, Bedford PA, Knight SC. Effects of murine leukemia viruses on the function of dendritic cells European Journal of Immunology. 23: 2932-2938. PMID 8223870 DOI: 10.1002/Eji.1830231131 |
0.412 |
|
Low-probability matches (unlikely to be authored by this person) |
2016 |
Caino MC, Seo JH, Aguinaldo A, Wait E, Bryant KG, Kossenkov AV, Hayden JE, Vaira V, Morotti A, Ferrero S, Bosari S, Gabrilovich DI, Languino LR, Cohen AR, Altieri DC. A neuronal network of mitochondrial dynamics regulates metastasis. Nature Communications. 7: 13730. PMID 27991488 DOI: 10.1038/Ncomms13730 |
0.3 |
|
2003 |
Pisarev V, Yu B, Salup R, Sherman S, Altieri DC, Gabrilovich DI. Full-length dominant-negative survivin for cancer immunotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 6523-33. PMID 14695157 |
0.299 |
|
2018 |
Lu H, Bowler N, Harshyne LA, Craig Hooper D, Krishn SR, Kurtoglu S, Fedele C, Liu Q, Tang HY, Kossenkov AV, Kelly WK, Wang K, Kean RB, Weinreb PH, Yu L, ... ... Gabrilovich DI, et al. Exosomal αvβ6 integrin is required for monocyte M2 polarization in prostate cancer. Matrix Biology : Journal of the International Society For Matrix Biology. PMID 29530483 DOI: 10.1016/J.Matbio.2018.03.009 |
0.298 |
|
2022 |
Perego M, Fu S, Cao Y, Kossenkov A, Yao M, Alicea-Torres K, Liu W, Jiang Z, Chen Z, Fuchs SY, Zhou J, Gabrilovich DI. Mechanisms regulating transitory suppressive activity of neutrophils in newborns: PMNs-MDSCs in newborns. Journal of Leukocyte Biology. PMID 35726818 DOI: 10.1002/JLB.4HI0921-514RR |
0.297 |
|
2016 |
Ager C, Reilley M, Nicholas C, Bartkowiak T, Jaiswal A, Curran M, Albershardt TC, Bajaj A, Archer JF, Reeves RS, Ngo LY, Berglund P, ter Meulen J, Denis C, Ghadially H, ... ... Gabrilovich D, et al. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two Journal For Immunotherapy of Cancer. 4. DOI: 10.1186/S40425-016-0173-6 |
0.297 |
|
2006 |
Gabrilovich DI. Gr-1 positive immature myeloid cells and T cell tolerance Modern Aspects of Immunobiology. 18: 4. |
0.297 |
|
2006 |
Gabrilovich DI. INGN 201 (Advexin): adenoviral p53 gene therapy for cancer. Expert Opinion On Biological Therapy. 6: 823-32. PMID 16856803 DOI: 10.1517/14712598.6.8.823 |
0.296 |
|
2018 |
Karakasheva TA, Dominguez GA, Hashimoto A, Lin EW, Chiu C, Sasser K, Lee JW, Beatty GL, Gabrilovich DI, Rustgi AK. CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients. Jci Insight. 3. PMID 29563330 DOI: 10.1172/Jci.Insight.97022 |
0.28 |
|
2018 |
Agarwala SS, Moschos SJ, Johnson ML, Opyrchal M, Gabrilovich D, Danaher P, Wang F, Brouwer S, Ordentlich P, Sankoh S, Schmidt EV, Meyers ML, Sullivan RJ. Efficacy and safety of entinostat (ENT) and pembrolizumab (PEMBRO) in patients with melanoma progressing on or after a PD-1/L1 blocking antibody. Journal of Clinical Oncology. 36: 9530-9530. DOI: 10.1200/Jco.2018.36.15_Suppl.9530 |
0.279 |
|
2017 |
Creelan BC, Gabrilovich DI, Gray JE, Williams CC, Tanvetyanon T, Haura EB, Weber JS, Gibney GT, Markowitz J, Proksch JW, Reisman SA, McKee MD, Chin MP, Meyer CJ, Antonia SJ. Safety, pharmacokinetics, and pharmacodynamics of oral omaveloxolone (RTA 408), a synthetic triterpenoid, in a first-in-human trial of patients with advanced solid tumors. Oncotargets and Therapy. 10: 4239-4250. PMID 28919776 DOI: 10.2147/Ott.S136992 |
0.278 |
|
2020 |
Gui J, Zahedi F, Ortiz A, Cho C, Katlinski KV, Alicea-Torres K, Li J, Todd L, Zhang H, Beiting DP, Sander C, Kirkwood JM, Snow BE, Wakeham AC, Mak TW, ... ... Gabrilovich DI, et al. Activation of p38α stress-activated protein kinase drives the formation of the pre-metastatic niche in the lungs. Nature Cancer. 1: 603-619. PMID 34124690 DOI: 10.1038/s43018-020-0064-0 |
0.276 |
|
2009 |
Finkelstein S, Gabrilovich D, Bui M, Cotter M, Cheong D, Gonzalez R, Heysek R, Sondak V, Letson G, Antonia S. At the Confluence of Radiation Therapy and Immunotherapy: External Beam Radiation (EBRT) with Intratumoral Injection of Dendritic Cells as Neoadjuvant Treatment of High-risk Soft Tissue Sarcoma Patients International Journal of Radiation Oncology*Biology*Physics. 75: S65. DOI: 10.1016/J.Ijrobp.2009.07.166 |
0.275 |
|
1996 |
Chen HL, Gabrilovich D, Tampé R, Girgis KR, Nadaf S, Carbone DP. A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer. Nature Genetics. 13: 210-3. PMID 8640228 DOI: 10.1038/ng0696-210 |
0.275 |
|
2019 |
Dominguez GA, Roop J, Polo A, Campisi A, Gabrilovich DI, Kumar A. Abstract 918: Using machine learning to predict the risk of either having an aggressive form of prostate cancer (PCa) or lower-grade PCa/benign prostatic hyperplasia (BPH) based upon the flow cytometry immunophenotyping of myeloid-derived suppressor cells (MDSCs) and lymphocyte cell populations Cancer Research. 79: 918-918. DOI: 10.1158/1538-7445.Am2019-918 |
0.274 |
|
1999 |
Ishida T, Chada S, Stipanov M, Nadaf S, Ciernik FI, Gabrilovich DI, Carbone DP. Dendritic cells transduced with wild-type p53 gene elicit potent anti-tumour immune responses. Clinical and Experimental Immunology. 117: 244-51. PMID 10444254 DOI: 10.1046/j.1365-2249.1999.00913.x |
0.274 |
|
1999 |
Ohm JE, Shurin MR, Esche C, Lotze MT, Carbone DP, Gabrilovich DI. Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo Journal of Immunology. 163: 3260-3268. PMID 10477595 |
0.273 |
|
2007 |
Gabrilovich DI. Molecular mechanisms and therapeutic reversal of immune suppression in cancer. Current Cancer Drug Targets. 7: 1. PMID 17305473 |
0.271 |
|
2010 |
Noyes D, Lenox B, Bui M, Cheong D, Gonzalez R, Heysek R, Zager J, Antonia S, Gabrilovich D, Finkelstein S. Serum IL-R1a and IP-10 Cytokine/chemokine Profiling Differences in Immune Responders and Non-responders to Combination Radiation / Immunotherapy for Soft Tissue Sarcoma International Journal of Radiation Oncology*Biology*Physics. 78: S85-S86. DOI: 10.1016/J.Ijrobp.2010.07.230 |
0.271 |
|
2020 |
Dominguez GA, Roop J, Polo A, Campisi A, Gabrilovich DI, Kumar A. Abstract B50: Using pattern recognition neural networks to detect prostate cancer: A new method to analyze flow cytometry-based immunophenotyping using machine learning Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Liqbiop20-B50 |
0.27 |
|
2007 |
Gabrilovich D. Editorial [Hot Topic: Molecular Mechanisms and Therapeutic Reversal of Immune Suppression in Cancer (Guest Editor: Dmitry I. Gabrilovich)] Current Cancer Drug Targets. 7: 1-1. DOI: 10.2174/1568009610707010001 |
0.269 |
|
2014 |
Mohammadyani D, Tyurin VA, O'Brien M, Sadovsky Y, Gabrilovich DI, Klein-Seetharaman J, Kagan VE. Molecular speciation and dynamics of oxidized triacylglycerols in lipid droplets: Mass spectrometry and coarse-grained simulations. Free Radical Biology & Medicine. 76: 53-60. PMID 25110833 DOI: 10.1016/J.Freeradbiomed.2014.07.042 |
0.268 |
|
2008 |
Hurwitz AA, Gabrilovich DI. Immune-suppressive mechanisms and cancer: Understanding the implications, paradoxes, and burning questions Tumor Induced Immune Suppression: Mechanisms and Therapeutic Reversal. 1-5. DOI: 10.1007/978-0-387-69118-3_1 |
0.268 |
|
1998 |
Oyama T, Ran S, Ishida T, Nadaf S, Kerr L, Carbone DP, Gabrilovich DI. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-κB activation in hemopoietic progenitor cells Journal of Immunology. 160: 1224-1232. PMID 9570538 |
0.267 |
|
2020 |
Dominguez GA, Polo AT, Roop J, Campisi AJ, Somer RA, Perzin AD, Gabrilovich DI, Kumar A. Detecting Prostate Cancer Using Pattern Recognition Neural Networks With Flow Cytometry-Based Immunophenotyping in At-Risk Men. Biomarker Insights. 15: 1177271920913320. PMID 32341637 DOI: 10.1177/1177271920913320 |
0.267 |
|
2018 |
Lei AH, Xiao Q, Liu GY, Shi K, Yang Q, Li X, Liu YF, Wang HK, Cai WP, Guan YJ, Gabrilovich DI, Zhou J. ICAM-1 controls development and function of ILC2. The Journal of Experimental Medicine. PMID 30049704 DOI: 10.1084/Jem.20172359 |
0.264 |
|
2019 |
Y Tyurina Y, Tyurin VA, Anthonymuthu T, Amoscato AA, Sparvero LJ, Nesterova AM, Baynard ML, Sun W, He R, Khaitovich P, Vladimirov YA, Gabrilovich DI, Bayir H, Kagan VE. "Redox lipidomics technology: Looking for a needle in a haystack". Chemistry and Physics of Lipids. PMID 30928338 DOI: 10.1016/J.Chemphyslip.2019.03.012 |
0.26 |
|
1996 |
Gabrilovich DI, Cunningham HT, Carbone DP. IL-12 and mutant p53 peptide-pulsed dendritic cells for the specific immunotherapy of cancer Journal of Immunotherapy. 19: 414-415. PMID 9041460 DOI: 10.1097/00002371-199611000-00005 |
0.258 |
|
2009 |
Zhou J, Cheng P, Youn JI, Cotter MJ, Gabrilovich DI. Notch and Wingless Signaling Cooperate in Regulation of Dendritic Cell Differentiation (DOI:10.1016/j.immuni.2009.03.021) Immunity. 31: 356. DOI: 10.1016/j.immuni.2009.07.003 |
0.253 |
|
2020 |
Dominguez GA, Roop J, Polo A, Campisi A, Gabrilovich DI, Kumar A. Abstract P5-01-16: Combining HyperVOX with pattern recognition neural networks: A new method for analyzing flow cytometry-based immunophenotyping data for increased early detection of stage I/II breast cancer (BCa) Cancer Research. DOI: 10.1158/1538-7445.Sabcs19-P5-01-16 |
0.251 |
|
2017 |
Patel S, Hodi F, Gabrilovich D, Chin M, Gibney G, Goldsberry A, Gonzalez R, Hurt J, Markowitz J, Whitman E, Meyer C, Salama A. A phase 1b/2 study of omaveloxolone in combination with checkpoint inhibitors in patients with unresectable or metastatic melanoma Annals of Oncology. 28: xi30. DOI: 10.1093/Annonc/Mdx760 |
0.247 |
|
2015 |
Ramachandran I, Lin C, Gabrilovich DI, Nefedova Y. Abstract 1364: Blocking of S100A9 with tasquinimod demonstrates a potent anti-myeloma activity Cancer Research. 75: 1364-1364. DOI: 10.1158/1538-7445.Am2015-1364 |
0.244 |
|
2020 |
Dorhoi A, Kotzé LA, Berzofsky JA, Sui Y, Gabrilovich DI, Garg A, Hafner R, Khader SA, Schaible UE, Kaufmann SH, Walzl G, Lutz MB, Mahon RN, Ostrand-Rosenberg S, Bishai W, et al. Therapies for tuberculosis and AIDS: myeloid-derived suppressor cells in focus. The Journal of Clinical Investigation. PMID 32420917 DOI: 10.1172/Jci136288 |
0.242 |
|
2003 |
Yu B, Kusmartsev S, Cheng F, Paolini M, Nefedova Y, Sotomayor E, Gabrilovich D. Effective combination of chemotherapy and dendritic cell administration for the treatment of advanced-stage experimental breast cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 285-94. PMID 12538481 |
0.238 |
|
2018 |
Liu YF, Zhang SY, Chen YY, Shi K, Zou B, Liu J, Yang Q, Jiang H, Wei L, Li CZ, Zhao M, Gabrilovich DI, Zhang H, Zhou J. ICAM-1 Deficiency in the Bone Marrow Niche Impairs Quiescence and Repopulation of Hematopoietic Stem Cells. Stem Cell Reports. PMID 29937143 DOI: 10.1016/J.Stemcr.2018.05.016 |
0.235 |
|
2018 |
Tang CA, Chang S, Paton AW, Paton JC, Gabrilovich DI, Ploegh HL, Del Valle JR, Hu CA. Phosphorylation of IRE1 at S729 regulates RIDD in B cells and antibody production after immunization. The Journal of Cell Biology. PMID 29511123 DOI: 10.1083/Jcb.201709137 |
0.234 |
|
2021 |
Trizzino M, Zucco A, Deliard S, Wang F, Barbieri E, Veglia F, Gabrilovich D, Gardini A. EGR1 is a gatekeeper of inflammatory enhancers in human macrophages. Science Advances. 7. PMID 33523892 DOI: 10.1126/sciadv.aaz8836 |
0.232 |
|
1996 |
Gabrilovich DI, Patterson S, Timofeev AV, Harvey JJ, Knight SC. Mechanism of dendritic cell dysfunction in retroviral infection in mice Clinical Immunology and Immunopathology. 80: 139-146. PMID 8764558 DOI: 10.1006/clin.1996.0107 |
0.23 |
|
1990 |
Shalygina NB, Astaf'eva NV, Shalygina AI, Serebrovskaia LV, Gabrilovich DI, Semashko MI, Khabarova VV. The cellular immune response in different forms of diphtheria in adults Zhurnal Mikrobiologii Epidemiologii I Immunobiologii. 84-88. PMID 2122622 |
0.23 |
|
2021 |
Du K, Wei S, Wei Z, Frederick DT, Miao B, Moll T, Tian T, Sugarman E, Gabrilovich DI, Sullivan RJ, Liu L, Flaherty KT, Boland GM, Herlyn M, Zhang G. Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanoma. Nature Communications. 12: 6023. PMID 34654806 DOI: 10.1038/s41467-021-26299-4 |
0.223 |
|
2018 |
Hellmann M, Jänne P, Opyrchal M, Hafez N, Raez L, Gabrilovich D, Wang F, Ordentlich P, Brouwer S, Sankoh S, Schmidt E, Meyers M, Ramalingam S. OA05.01 Efficacy/Safety of Entinostat (ENT) and Pembrolizumab (PEMBRO) in NSCLC Patients Previously Treated with Anti-PD-(L)1 Therapy Journal of Thoracic Oncology. 13: S330. DOI: 10.1016/J.Jtho.2018.08.257 |
0.223 |
|
1994 |
Gabrilovich DI, Woods GM, Patterson S, Harvey JJ, Knight SC. Retrovirus-induced immunosuppression via blocking of dendritic cell migration and down-regulation of adhesion molecules Immunology. 82: 82-87. PMID 8045596 |
0.217 |
|
2024 |
Chen X, Tsvetkov AS, Shen HM, Isidoro C, Ktistakis NT, Linkermann A, Koopman WJH, Simon HU, Galluzzi L, Luo S, Xu D, Gu W, Peulen O, Cai Q, Rubinsztein DC, ... ... Gabrilovich DI, et al. International consensus guidelines for the definition, detection, and interpretation of autophagy-dependent ferroptosis. Autophagy. PMID 38442890 DOI: 10.1080/15548627.2024.2319901 |
0.201 |
|
2017 |
Chen DT, Huang PY, Lin HY, Chiappori AA, Gabrilovich DI, Haura EB, Antonia SJ, Gray JE. A Bayesian pick-the-winner design in a randomized phase II clinical trial. Oncotarget. 8: 88376-88385. PMID 29179442 DOI: 10.18632/Oncotarget.19088 |
0.195 |
|
1995 |
Gabrilovich DI, Patterson S, Harvey JJ, Woods GM, Elsley W, Knight SC. Defects in the function of dendritic cells in murine retroviral infection. Advances in Experimental Medicine and Biology. 378: 469-72. PMID 8526120 |
0.195 |
|
2024 |
Dai E, Chen X, Linkermann A, Jiang X, Kang R, Kagan VE, Bayir H, Yang WS, Garcia-Saez AJ, Ioannou MS, Janowitz T, Ran Q, Gu W, Gan B, Krysko DV, ... ... Gabrilovich DI, et al. A guideline on the molecular ecosystem regulating ferroptosis. Nature Cell Biology. PMID 38424270 DOI: 10.1038/s41556-024-01360-8 |
0.183 |
|
2020 |
Hellmann MD, Janne PA, Opyrchal M, Hafez N, Raez LE, Gabrilovich DI, Wang F, Trepel JB, Lee MJ, Yuno A, Lee S, Brouwer S, Sankoh S, Wang L, Tamang D, et al. Entinostat plus pembrolizumab in patients with metastatic NSCLC previously treated with anti-PD-(L)1 therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 33203644 DOI: 10.1158/1078-0432.CCR-20-3305 |
0.182 |
|
2001 |
Dikov MM, Oyama T, Cheng P, Takahashi T, Takahashi K, Sepetavec T, Edwards B, Adachi Y, Nadaf S, Daniel T, Gabrilovich DI, Carbone DP. Vascular endothelial growth factor effects on nuclear factor-κB activation in hematopoietic progenitor cells Cancer Research. 61: 2015-2021. PMID 11280761 |
0.178 |
|
1990 |
Pokrovskiǐ VV, Gabrilovich DI, Serebrovskaia LV, Sundukova EI, Semashko MI, Khabarova VV, Shalygina NB. The lymphocyte populations at different stages in the infection caused by the human immunodeficiency virus Zhurnal Mikrobiologii Epidemiologii I Immunobiologii. 29-32. PMID 2343681 |
0.175 |
|
2007 |
Gabrilovich D. Dendritic Vaccines--Fifth International Meeting. Dendritic cell vaccination and other strategies to tip the balance of the immune system. 16-18 July 2007, Bamberg, Germany. Idrugs : the Investigational Drugs Journal. 10: 699-702. PMID 17899486 |
0.173 |
|
1992 |
Filatova TG, Gabrilovich DI, Serebrovskaia LV, Miasnikova EI, Vengerov II. The function of the blood cells and cerebrospinal fluid in patients with suppurative meningitis Terapevticheskii Arkhiv. 64: 31-34. PMID 1338137 |
0.168 |
|
1992 |
Gabrilovich DI, Shepeleva GK, Serebrovskaya LV, Avdeeva LA, Suvorova ZK, Rosly IM, Oganezov VK, Saidov MZ, Panyutich AV, Pokrovsky VV. Mononuclear cells from HIV-infected patients produce factors which enhance functional activity of polymorphonuclear neutrophils from healthy subjects Clinical and Experimental Immunology. 89: 362-368. PMID 1325304 |
0.167 |
|
2008 |
Corzo A, Nagaraj S, Gabrilovich DI. Role of reactive oxygen species in T-Cell defects in cancer Tumor Induced Immune Suppression: Mechanisms and Therapeutic Reversal. 259-280. DOI: 10.1007/978-0-387-69118-3_12 |
0.153 |
|
1991 |
Shalygina NB, Shalygina AI, Astaf'eva NV, Gabrilovich DI. Lymphocyte and neutrophil cytochemistry in the dynamics of different forms of diphtheria in adults Zhurnal Mikrobiologii Epidemiologii I Immunobiologii. 58-61. PMID 1650073 |
0.144 |
|
1993 |
Gabrilovich DI, Shepeleva GK, Serebrovskaya LV, Avdeeva LA, Pokrovsky VV. Modification of lymphocyte and monocyte functional activity by polymorphonuclear neutrophils in HIV infection Scandinavian Journal of Immunology. 37: 459-467. PMID 8469929 |
0.144 |
|
1994 |
Gabrilovich DI, Shepeleva GK, Serebrovskaya LV, Ivanova LA, Buravtsova EV, Pokrovsky VV. Modification of lymphocyte functional activity by neutrophils in HIV infection Immunologiya. 18-21. |
0.13 |
|
1992 |
Gabrilovich DI, Kozich AT, Moshnikov SA, Pokrovsky VV. The direct binding of an HIV fragment with granulocytes from healthy subjects and infected patients Scandinavian Journal of Immunology. 35: 369-372. PMID 1535992 |
0.123 |
|
2017 |
Tyurina YY, Shrivastava I, Tyurin VA, Mao G, Dar HH, Watkins S, Epperly M, Bahar I, Shvedova AA, Pitt B, Wenzel SE, Mallampalli RK, Sadovsky Y, Gabrilovich D, Greenberger JS, et al. "Only a life lived for others is worth living:" Redox Signaling by Oxygenated Phospholipids in Cell Fate Decisions. Antioxidants & Redox Signaling. PMID 28835115 DOI: 10.1089/ars.2017.7124 |
0.122 |
|
2007 |
Gabrilovich DI. Current Cancer Drug Targets: Editorial Current Cancer Drug Targets. 7: 1. |
0.12 |
|
1988 |
Gabrilovich DI, Shalygina NB, Zmyzgova AV, Musarov AL, Kuznetsova EN. Blood lymphocyte and neutrophil function in patients with viral non-A, non-B hepatitis and a fecal-oral mechanism of the transmission of infection Zhurnal Mikrobiologii Epidemiologii I Immunobiologii. 70-74. PMID 3137745 |
0.12 |
|
1994 |
Gabrilovich DI, Serebrovskaia LV, Khabarova VV, Kravchenko AV, Avdeeva LA, Shalygina NB, Pokrovskiǐ VV. Immune system indices for the prediction of the course of human immunodeficiency virus infection Zhurnal Mikrobiologii Epidemiologii I Immunobiologii. 114-118. PMID 7856337 |
0.118 |
|
1988 |
Gabrilovich DI, Serebrovskaya LV, Murzabaeva RT, Semashko MI, Zmyzgova AV, Shalygina NB. Influence of Reaferon on the functional activity of peripheral blood lymphocytes and neutrophils in volunteers Zhurnal Mikrobiologii Epidemiologii I Immunobiologii. 65. PMID 3389006 |
0.117 |
|
1990 |
Gabrilovich DI, Musarov AL, Zmyzgova AV, Shalygina NB. The use of hyperbaric oxygenation in treating viral hepatitis B and the reaction of the blood leukocytes Terapevticheskii Arkhiv. 62: 82-86. PMID 2333627 |
0.116 |
|
1991 |
Gabrilovich DI, Kozhich AT, Suvorova ZK, Ivanov VS, Moshnikov SA, Chikin LD, Kolezonkova OV, Pokrovsky VV. Influence of HIV antigens on functional activity of neutrophilic granulocytes in patients with HIV infection Scandinavian Journal of Immunology. 33: 549-552. PMID 2031147 DOI: 10.1111/j.1365-3083.1991.tb02525.x |
0.116 |
|
1991 |
Gabrilovich DI, Serebrovskaia LV, Khabarova VV, Semashko MI, Maksimov SL, Kokoreva LN, Shalygina NB, Pokrovskiǐ VV. The comparative characteristics of the indices of lymphocyte and neutrophil functional activity in patients with HIV infection and chronic viral hepatitis B Zhurnal Mikrobiologii Epidemiologii I Immunobiologii. 35-37. PMID 1679592 |
0.108 |
|
2022 |
Sharma G, Ojha R, Noguera-Ortega E, Rebecca VW, Attanasio J, Liu S, Piao S, Lee JJ, Nicastri MC, Harper SL, Ronghe A, Jain V, Winkler JD, Speicher DW, Mastio J, ... ... Gabrilovich DI, et al. PPT1 inhibition enhances the antitumor activity of anti-PD-1 antibody in melanoma. Jci Insight. 7. PMID 36278493 DOI: 10.1172/jci.insight.165688 |
0.098 |
|
1991 |
Gabrilovich DI. Discrete dynamic analysis of the functional activity of the leukocytes in predicting the nature of the course of viral hepatitis Laboratornoe Delo. 67-69. PMID 1710728 |
0.091 |
|
1992 |
Iurin OG, Irova TI, Gabrilovich DI, Suvorova ZK, Kravchenko AV, Potekaev NS, Kharchenko OI, Pokrovskiǐ VV. Clinical manifestations and the problems of classification of HIV infection Vestnik Rossiiskoi Akademii Meditsinskikh Nauk / Rossiiskaia Akademiia Meditsinskikh Nauk. 16-19. PMID 1283710 |
0.091 |
|
2020 |
Gui J, Zahedi F, Ortiz A, Cho C, Katlinski KV, Alicea-Torres K, Li J, Todd L, Zhang H, Beiting DP, Sander C, Kirkwood JM, Snow BE, Wakeham AC, Mak TW, ... ... Gabrilovich DI, et al. Activation of p38α stress-activated protein kinase drives the formation of the pre-metastatic niche in the lungs Nature Cancer. 1: 603-619. DOI: 10.1038/s43018-020-0064-0 |
0.088 |
|
1991 |
Gabrilovich DI, Kozhich AT, Rosly IM, Suvorova ZK, Ivanov VS, Moshnikov SA, Tchikin LD, Melichov VI, Pokrovsky VV. The synthetic peptide from HIV increases functional activity of granulocytes in healthy subjects Aids. 5: 889-892. PMID 1892596 |
0.087 |
|
1994 |
Gabrilovich D, Ivanova L, Serebrovskaya L, Shepeleva G, Pokrovsky V. Clinical significance of neutrophil functional activity in HIV infection. Scandinavian Journal of Infectious Diseases. 26: 41-7. PMID 8191239 DOI: 10.3109/00365549409008589 |
0.087 |
|
1992 |
Pokrovsky VV, Yurin OG, Kravchenko AV, Potekaev NS, Gabrilovich DI, Makarova Yu. N, Potekaev SN. First case of HIV infection in a citizen of the USSR Zhurnal Mikrobiologii Epidemiologii I Immunobiologii. 69: 19-22. PMID 1301654 |
0.085 |
|
1995 |
Gabrilovich DI, Ivanova LA, Shepeleva GK, Serebrovskaia LV, Buravtsova EV, Pokrovskii VV. The effect of the blood serum factors of HIV-infected persons on the functional activity of the neutrophils in healthy donors Zhurnal Mikrobiologii, Epidemiologii, I Immunobiologii. 56-60. PMID 8525735 |
0.082 |
|
1984 |
Gabrilovich IM, Gabrilovich DI, Kantsaliev LB, Nagoev BS. Functional-metabolic activity of neutrophil granulocytes in donor blood as affected by oxygenation Laboratornoe Delo. 522-525. PMID 6210400 |
0.082 |
|
1987 |
Pokrovskiǐ VI, Nagoev BS, Gabrilovich DI, Ibragimov BM. Changes in the nonspecific factors of body protection in experimental Salmonella infection Byulleten Eksperimentalnoi Biologii I Meditsiny. 103: 276-278. PMID 3548838 |
0.078 |
|
1993 |
Gabrilovich DI, Avdeeva LA, Serebrovskaya LV, Shepeleva GK, Suvorova ZK, Buravcova EV, Oganezov VK, Platonov AE, Habarova VV, Posly IM, Pokrovsky VV. Impact of HIV-positive sera on the functional activity of polymorphonuclear neutrophils from healthy donors Scandinavian Journal of Immunology. 37: 159-164. PMID 8434229 |
0.073 |
|
1993 |
Pinegin BV, Saidov MZ, Scheltsyna TL, Gabrilovich DI, Khaitov RM. Peripheral blood neutrophils from HIV-1-infected individuals armed with factors that cause inhibition of their migration in response to specific antigens Immunology Letters. 36: 13-17. PMID 8344712 DOI: 10.1016/0165-2478(93)90062-7 |
0.072 |
|
2013 |
Kim S, Ramakrishnan R, Gabrilovich D. Impact of Radiation-Induced Autophagy on the Efficacy of Combination Radiation Therapy and Immunotherapy International Journal of Radiation Oncology*Biology*Physics. 87: S632. DOI: 10.1016/J.Ijrobp.2013.06.1671 |
0.072 |
|
1990 |
Pokrovsky VV, Gabrilovich DI, Serebrovskaya LV, Melikhov VI, Semashko MI, Khabarova VV, Yurkiv VA, Shalygina NB, Yaroshenko IK, Sundukova Yu. E. Lymphocyte number and functional activity in HIV-infected citizens of the USSR and African natives Immunologiya. 27-28. |
0.069 |
|
2014 |
Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, ... ... Gabrilovich DI, et al. Classification of current anticancer immunotherapies Oncotarget. 5: 12472-12508. |
0.067 |
|
1988 |
Gabrilovich DI, Cherkasova TD, Zmyzgova AV, Shalygina NB. Relationship between theophylline-sensitivity and cyclic nucleotide content in lymphocytes in patients with non-A-non-B virus heptitis Immunologiya. 67-69. |
0.067 |
|
1995 |
Gabrilovich DI, Vasilev VB, Nosikov VV, Serebrovskaia LV, Shepeleva GK, Ivanova LA, Pokrovskii VV. The presence of HIV DNA in the neutrophils of persons infected with the human immunodeficiency virus and the clinical parallels of this phenomenon Zhurnal Mikrobiologii, Epidemiologii, I Immunobiologii. 52-55. PMID 8525734 |
0.052 |
|
1988 |
Pokrovsky VI, Zmyzgova AV, Murzabaeva RT, Fomina TN, Shalygina NB, Makarova GV, Novikova TA, Polyakova AM, Kuznetsova EN, Gabrilovich DI, Semashko MI, Serebrovskaya LV. Study of the reactogenicity, toxicity and tolerance of reaferon in healthy volunteers Zhurnal Mikrobiologii Epidemiologii I Immunobiologii. 65. PMID 3364074 |
0.049 |
|
1992 |
Gabrilovich DI, Vassilev V, Nosikov VV, Serebrovskaya LV, Kravchenko AV, Pokrovsky VV. Presence of HIV DNA in neutrophils: Relationship to their functional activity [9] Aids. 6: 134-136. PMID 1543560 |
0.046 |
|
1987 |
Pokrovskii VI, Nagoev BS, Gabrilovich DI, Ibragimov BM. Changes in some nonspecific defensive factors in experimental salmonella infection Bulletin of Experimental Biology and Medicine. 103: 302-304. DOI: 10.1007/BF00840543 |
0.039 |
|
2017 |
Chen DT, Huang PY, Lin HY, Chiappori AA, Gabrilovich DI, Haura EB, Antonia SJ, Gray JE. A Bayesian pick-the-winner design in a randomized phase II clinical trial. Oncotarget. PMID 28706157 DOI: 10.18632/oncotarget.19088 |
0.038 |
|
1993 |
Gabrilovich DI, Vassilev V, Nosikov VV, Serebrovskaya LV, Ivanova LA, Pokrovsky VV. Clinical significance of hiv dna in polymorphonuclear neutrophils from patients with hiv infection Journal of Acquired Immune Deficiency Syndromes. 6: 587-591. PMID 8388451 |
0.036 |
|
1985 |
Nagoev BS, Gabrilovich DI. Modified method of determining the neutrophil damage index using fluorescent microscopy Laboratornoe Delo. 378-380. PMID 2413269 |
0.029 |
|
1992 |
Gabrilovich DI, Irova TI, Kuznetsova VV, Khabarova VV, Serebrovskaia LV, Pokrovskiǐ VV. Immunologic changes in the process of the treatment of children with HIV infection using azidothymidine Vestnik Rossiiskoi Akademii Meditsinskikh Nauk / Rossiiskaia Akademiia Meditsinskikh Nauk. 21-24. PMID 1283712 |
0.025 |
|
2014 |
Gabrilovich DI. Preface The Tumor Immunoenvironment. v-vi. DOI: 10.1007/978-94-007-6217-6 |
0.01 |
|
Hide low-probability matches. |